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1 - HISTORY
Our knowledge of the endocrine functions of the
pituitary gland is comparatively recent* Text-books of
physiology published in the late 19th century (e.g*
Michael Post Text-Book of Physiology, 1891 edition) gave
a good histological description of the gland, emphasised
its ductless nature, but could attribute no definite
function to it.
The first evidence suggesting any function for the
ft
pituitary body was presented by Oliver and 0chafer in
1895* They observed that extracts from the whole pit¬
uitary gland had a pressor activity when injected intra¬
venously into the anaesthetised dog.
Howell (1898) showed that the substance responsible
for this pressor action of pituitary extracts was
obtainable only from one part of the organ, and rather
surprisingly, only from its posterior, neural lobe. At
the time this appeared to be quite an anomalous finding,
as the main glandular structures were known to be local-
ised to the anterior lobe of the pituitary.
Bale (1906) discovered the oxytocic action of post¬
erior pituitary extracts by mere chance. hilst invest¬
igating the sympatholytic action of certain ergot
alkaloids he recorded the uterine activity as well as
the arterial blood pressure of a pregnant female cat.
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The effects of adrenaline on both target organs were
reversed by a previous dose of the ergot preparation.
For the sake of comparison, Dale then injected a dose
of a posterior pituitary extract, when he noticed that
it had not only retained its normal pressor action but
it also produced a profound contractile response of
the uterus#
The milk-ejecting properties of the posterior
pituitary extracts were demonstrated a few years later
by Ott and Scott (1910)# However, the greatest
controversy centred around the effects on the rate of
urine secretion# Magnus and Schafer (1901) observed
that an intravenous injection of the pituitary posterior
lobe extracts into an anaesthetised animal produced,
after a latent period, a conspicuous increase in the
rate of flow of urine; i.e# a diuretic response# This
observation was confirmed by Schafer and Bering (1906}
and Dale (1909)# Later, Schafer (1909) subjected the
pituitary glands of dogs to themo-cautery, and noted
that polyuria supervened during the post-operative
period# Frank (1912) discovered a strong pathological
association between human diabetes insipidus and disease
or injury of the neurohypophysis. He attributed the
disease to excessive pouring of the supposed diuretic
hormone evoked by irritation of the neurohypophysis.
Parrni (1913) and Van den Velden (1913) independently
investigated the effect of injection of posterior
pituitary extracts on the course of the disease in cases
of diabetes insipidus. They both reported a favourable
result which cast doubt on the earlier diuresis finding
of Cchafer and Prank's application of this idea to his
pathological study. Konsehegg and Schuaten (1915) re-
investigated the problem in conscious animals and proved
that the true action of posterior pituitary gland
extracts on the kidney is antidiuretic. The earlier
an
finding of Schafer, was recognised to be/artefact
resulting from the depression of kidney function pro¬
duced by anaesthesia, and to the injection of compar¬
atively large doses of the extract by the intravenous
route.
The earlier concept by Dale (1909) that these
different effects of pituitary extracts were due to one
and the same hormone was also subsequently disproved
by fractionation of the extracts into two constituents,
of which one is mainly oxytocic and the other is vaeo-
pressor and antidiuretic (Dudley, 1919) • Separation was
achieved on a commercial scale by Kamm et al (1928) in
the laboratories of Park Davis and Company. Since then,
preparations have been available for clinical use of
comparatively pure oxytocin (pitocin) and vasopressin
(pitressin).
In 19h9» Livemore and Pu Vigneaud were able to
isolate the hormones in a chemically pure form from the
pituitary extracts of animals. This was the starting
point for elucidating their molecular structure. The
k
chemical formula of oxytocin was worked out independ¬
ently by Du Vigneaud et al (1953)^ in New York* and
Tuppy (1953) in Vienna, employing completely different
degradation techniques. Tuppy published his finding
a few weeks before Du Vigneaud et al. However, Du
Vigneaud and his co-workers (1953) were also able to
b
prove the formula by synthesising the hormone. This
was the first polypeptide hormone to be synthesised,
and for this Du Vigneaud was awarded the Nobel prize
for chemistry in 1955» The chemical formula for vaso¬
pressin was subsequently established by Du Vigneaud et al
(1953) and the proposed structure was also proved by
0
synthesis.
It must be emphasised that advance in oxytocin and
vasopressin research was comparatively rapid when
compared to other polypeptide hormones e.g. insulin.
This is largely du© to the fact that the former hormones
are easily extracted from mammalian posterior pituitaries
by dilute acetic acid in which they are very stable.
Such simple extracts were employed by Bell In obstetric
practice as early as 1909*
2 - CIivMI8THY AND SYNTHETIC ANALOGUES
Chemically, human oxytocin and vasopressin proved to
be relatively simple octapeptides (molecular weight
approximately 1000) with closely interrelated structures

















































The structural formula of oxytocin.
figure 1
amino acid residues is the one suggested by Bo&ansky and
Du Vigneaud (1959) and is shown in Pig* 2* Thus, human
oxytocin and vasopressin share six common araino acid
residues with differences only in position 3 (iso-
leucine in the oxytocin molecule being replaced by pheny¬
lalanine in vasopressin), and position 8 (where an
arginine residue in vasopressin replaces leucine in oxy-
tocln)*
Investigation of neurohypophysial hormones in post¬
erior pituitary extracts of various animal species has
so far revealed the presence of some other peptide
variants, namely:
a Lysine - Vasopressin in the hog (Pig* 2)
b Vasotocin (3-1-leucine, 8-arginine oxytocin in
birds, frogs and fishes (Pig* 2)
c leotocin (3-1-leu*, h-serlne, 8-1-leucine oxy¬
tocin) in fishes (Pig* 2)
All natural posterior pituitary hormones thus seera
to share five common araino acids, showing differences
only in positions 3» k and 8 of the molecule* They also
share the following chemical features:-
1 A dlsulphide bond between the two half-cystine
residues in positions 1 and 6* Disruption of
this bond by reduction or oxidation leads to loss
of biological activity.
2 A cyclic pentapeptide ring involving the residues
1 to 6, and comprising exactly 20 carbon atoms*
Oxytocin
123 4 5 678 9
CyS- Tyr - lieu - Glu(NH2)- Asp(NH2) - CyS- Pro - Leu - Gly(NH2)
Arginine Vasopressin
CyS-Tyr - Phe - Glu(NH2) - Asp(NH2) - CyS -Pro - Arg - Gly(NH2)
Lysine Vasopressin




Ileuj- CluCNHs)-Asp(NH2) - CyS - Pro - Arg - Gly(NH2)
Isotocin
Cy S-Tyr - lieu — Ser —Asp(NH2) - CyS - Pro - lieu - Cly(NH2)
igure 2 '\iuino Acid Sequence of Polypeptides from the Post¬
erior Pituitary Olan&s of Man and Animals.
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3 A free amino group in position 1.
Although the differences in the chemical structure
of the natural hormones are relatively small, the above
peptides show vast contrasts in biological activities as
evaluated by various pharmacological techniques# This
fact has stimulated research in the field of synthetic
analogues of oxytocin and vasopressin# Over the past
decade more than a hundred of these analogues have been
syntheslsed and assessed biologically, mainly by Du
Vigneaud and co-workers, Bioosonnas et al (1956), and
by Hudinger (196b), As pointed out by Berde (19&h), the
aim of these studies is
a To study the relation between chemical structure
and biological activity, e#g. it is now established
that a basic amino acid in position 8, such as
argininc, lysine or histidlne, enhances the anti¬
diuretic effect of the molecule#
b To produce polypeptides with modified spectrum
of activity which ©re useful for specific
clinical purposes and are free from undesirable
side effects,
c To produce compound© which prove to have
antagonistic properties to oxytocin and vaso¬
pressin for clinical trial.
So far the only synthetic analogues which have
proved to be of clinical value are Octapressin (Berde,
196k) and 1-Besamlno-oxyfcocin (Du Vigneaud et al, 1960)
CyS - Phe - Phe - Glu (NH2) ~ AspCNhh) -CyS - Pro - Lys - GlyCNHfe)
Chemical Structure of Octapressin.
(2-phenyl alanine. 8-lysine Vasopressin)
CH2-CH2-CO-Tyr - lieu - Glu(NhQ - Asp(NH2)~CyS - Pro - Leu-GlyCNhb)
S 1
Chemical Structure of l-Desamino-Oxytocin.
Synthetic Analogues of Oxytocin of Therapeutic
Value.
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which are shown In Pig. 3» Octapressin has a marked
vasoconstrictor effect with little antidiuretic or
oxytocic action and is useful as a haemostatic agent in
surgical and gynaecological operations. 1 -Desami.no-
oxytocin has a high oxytocic activity on the human
uterus (J$nbrey, 19&5) * an(* per unit weight it is almost
twice as potent as oxytocin itself.
3 - METHODS OF ASSAY
In spite of the great advances in the chemistry of
neurohypophysial hormones, there is yet no chemical
method for their estimation. Various pharmacological
preparations are thus employed fox* their biological
assay. Table® 1 and 2 summarise the biological assay
methods for oxytocin and vasopressin respectively.
In all tests unknown quantities of the hormones
are matched to dose® of an International Standard (or
a substandard derived from It), and the result is exp¬
ressed in international units. By definition one Inter¬
national unit of either oxytocin or vasopressin is
equivalent to the activity of 0.5 rag* of a standard
acetone dried preparation of ox posterior pituitary
gland. This corresponds to approximately 2 ^ug. of the
pure synthetic hormones.
The assay of oxytocin and vasopressin in blood and
other biological fluids presents many technical difficul¬
ties (Walker, 1960). These include
a The physiological concentration of thea© hormones
TABLE1
HI0-A83AY3KTH0PSFORQXYTOCI




Hoiton,19U8 Pitzpatrick, 1961 Coon,1939
2-3 0.08-0.30 0.150
VanDykeetl, 1955 Pit?,patrick, 1961 Mendez-Bauer, etal,1960
0.005-0.010 0.05-0.30






Unanaesthetised,wa erlo ded Hypophysectornis d,unan&esthetised, waterloaded Paraldehydeana sth sia,w ter loaded Unanaesthetised,wa rlo ded
Mouse
Ethanolanaesthesia,continuous waterlo d,dosesinject dI/V Waterlo d*Hoanaesthesia
References Theobald,1934 Hareetl, 1945 Walker,1939 Bum,1931? C>insbjU.i»g,1§51 Dieker,1953 Hellerand Blackmore, 1952
bPressorActivity Method
Chloretoneana sthesia Spinalreparatio ,cthanaes¬ thesia,braindestruction, artificialrespirat on Barbiturateanaesth sia,p hing ofspinalcord Urethaneanaesth sia,hypo ensive agent
Approximate sensitivity peranimal ra.U,
References
+—20
Hamiltonnd ROT,'©,1916 Hogbenand 3chlapp,1924 Landgrebe etal,19**6; I>ebanlski,1951 British Pharmacopoeia,1963
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in peripheral venous blood is very low and is beyond
the sensitivity of the usual assay methods# This
difficulty can be overcome byt
tri
1 The use of hypertensive methods for assay, e.g.
euperfuaed rat's uterua for oxytocin estimation.
2 Collection of central venous blood from the
jugular veins into which the pituitary secretions
drain and would thus be present in higher
concentrations. In rat and sheep the external
jugular vein drains most of the blood from the
neurohypophysis and is relatively easy to
approach. In other species including man,
internal jugular venous blood is required.
3 Extraction and concentration of the hormones
from the biological media before the final
assay. Several methods have been described,
including acid ethanol extraction (Bisset, 1961)
for whole blood; acetone extraction for serum
(Fltspatrick, 1961); and gel filieration of
plasma on saphadex G~25 columns (Policy and
Enaggs, 1365). These methods involve a variable
loss of activity. In addition, the first two
commonly lead to concentration of interfering
substances which affect the assay preparation.
b Biological fluids commonly contain interfering
substances which affect the biological preparations
used for assay. Thus the isolated rat uterus preparation
12
commonly used fop assay of oxytocin ie affected by
excess of potassium ions, adrenaline,, serotonin, and
vasopressin* all of which are present in blood# Plasma
kinins, which similarly affect the rat uterus, are
released on contact with glass containers used for
collection# To minimise fallacious readings from these
non-specific interfering substances, the following
precautions are commonly used:
( i) Collection of samples in plastic pre-
cooled containers#
( ii) Dialysis of material before assay#
(lii) Use of thioglycollate to ascertain that the
noticed activity is due to oxytocin or
vasopressin# Thioglycollate in appropriate
molar concentration disrupts the disulphide
bond of the active peptides and leads to
loss of their biological activity. Bio¬
logical activity not abolished by thiogly¬
collate is considered not due to oxytocin
or vasopressin#
( iv) Chromatography of the final extract on
paper with a control run of the pure active
principle# The active polypeptide in the
extract is identified either by staining,
or by olution of the area corresponding to
the control followed by biological assay of
the eluate#
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Recently G'illlard and Thadd^us (1965} explored
the antigenic properties of oxytocin in the rabbit, and
could demonstrate specific antibody formation. Their
work indicates the feasibility of an immuno-assay
approach to posterior pituitary hormones.
h ORIGIN. STORAGE AMD RELEASE
There is ample histochemical and electronmicroscopic
evidence that oxytocin and vasopressin are actually
produced in the hypothalamic nuclei, carried along the
neurone axons in the pituitary stalk as stainable neuro¬
secretory material, and only stored in relation to the
nerve endings (pituicytes) in the posterior lobe of the
pituitary gland (Scharrer and Scharrer, J\95k) • There
is no agreement, however, on their exact form of
existence in the neurohypophysis. Van Dyke et al (19U1)
■
isolated a protein substance (molecular weight 30.000)
from beef posterior pituitary glands which contains
oxytocin and vasopressin in a fixed 1:1 ratio. The
active protein cannot be removed from Van Dyke protein
by dialysis against water, but can be liberated by
dialysis against 0.1 N acetic acid, electrodiolysis, or
trichloracetic acid precipitation (Acher and Promageot,
1959)« Since these gentle processes do not hydrolyse
peptide bonds, it appears unlikely that the active pep¬
tides are fragments of the Van Dyke protein. It is more
likely that the protein represents the "carrier substance
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to which the peptides are bound in a relatively loose
association during transport and storage within the
neurohypophysis.
Release or the active hormones fro® c.he gland can
be affected by a wide variety of stimuli including:
1 Direct electrical stimulation of the posterior
lobe of the pituitary gland and the associated
neurohypophysial-hypothalamic tracts.
2 Administration of drugs, notably nicotine,
acetylcholine, hexamethonium, morphine, many
tranquillisers and anaesthetic agents, "uthyl
alcohol, on the other hand, inhibits release
of the endogenous hormones and is widely emp¬
loyed for anaesthetising animals for their in
vivo biological assay. Hypertonic Intravenous
infusions of saline are also a potent method
for stimulating release of the hormones of the
posterior pituitary, probably through stimulation
of osmoreceptors in the hypothalamic region.
3 Physiological stimuli Include dehydration
(probably by increase in plasma osmolarity),
suckling, probably during childbirth, and possibly
during mating. Reduction of the circulatory
volume by haemorrhage or shock can also be an
effective stimulus.
There is no agreement on the selective release of
the individual hormones. Effective stimuli in most
instances appear to provoke the release of both oxytocin
15
and vasopressin into the circulation, commonly in a
fixed ratio with oxytocin invariably in excess to vaso¬
pressin (Pickford, 1960)• However, there is come
evidence on the separate release of the two hormones
individually in human experiments (Theobald, 1959; Cobo
et al, 1965).
There is also some doubt about the form In which
the hormones are carried in the blood. Thorn and Silver
(1957) suggest that neurohypophysial peptides are
partially bound to plasma proteins In an easily dissoc¬
iable form. Qinsburgi and Smith (1959) observed
however, that injected doses of peptides difsuee into
volumes approaching total body water indicating that
such binding is neither complete nor irreversible. A
similar finding was reported by Heller (1957).
THRQLK OF QXYTOCIN AMD VASOPRESSIN IK RRPRCngOTIV^
.OTaSChoqy
1 OXYTOCIA ATIP NATURAL CHILDBIRTH
Oxytocin is known to accelerate labour by eliciting
or re-inforcing contractions of the uterine smooth
muscle in many species including «ian. This property
finds wide clinical application both for induction of
labour (Theobald et al, 1548), and for treatment of
uterine Inertia in labour. This action of oxytocin is
mediated through a direct effect on receptors in the
smooth muscle cells of the uterus and can be demonstrated
in vivo as well an in vitro. From electrophysiological
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studies on rat uterus (Jung, 1961) and rabbit myometrium
(Csapo, 1961) it appears that the primary action of oxy¬
tocin on the uterine muscle is to lower the membrane
potential. In high concentrations, oxytocin also exerts
a direct effect on the contractile system of the myometrial
cells, even when the membrane is depolarised (£;vans et al
1998).
The sensitivity of the uterus to neurohypophysial
hormones depends on many factors, Including species,
hormonal and reproductive status and ionic milieu
(Van Dyke, 1961). There is general agreement that in
human pregnancy there is progressive rise in myometrial
sensitivity to oxytocin (Pose and Caldeyro-Barcia, 1968,
and Fltzpatrick, 1957)* According to Caldeyro-Barcia,
the sensitivity reaches a maximum in the last four weeks
of pregnancy, with no further change occurring in pre-
labour days. Smyth (1958) on the other hand, reported
a sharp increase in uterine sensitivity to oxytocin in
the few days preceding labour. Although the techniques
employed were different (Pose and Caldeyro-Barcia
assessed the myometrial sensitivity from the uterine
response to various doses of oxytocin administered in a
continuous intravenous drip, whereas Smyth injected oxy¬
tocin in interrupted doses of 10 mU/minute) there is
still no plausible explanation for the different results.
The Increased uterine sensitivity to oxytocin in
pregnancy is generally attributed to the existing high
levels of ©estrogens. Oestrogens are known to increase
1?
the sensitivity of the myometrium to oxytocin (Ceapo,
1961; Schofield, 1957)•
'
The role of progestrone in suppressing uterine
reactivity to oxytocin is subject to considerable contro¬
versy and apparently ©hows wide species differences# The
rabbit represents a classical example of a mammal in
which progestrone renders the myometrium refractory to
oxytocin (Csspo, 1961)# In human pregnancy, however,
large doses of progestrone fall to decrease the sensit¬
ivity of the uterus or to delay the onset of spontaneous
labour (Pose and Pielitz, 1961)• There is also no
evidence that progestrone levels in blood drop in late
pregnancy or at the time of labour (Short, 19&0) when
the reactivity of the myometrium is at its zenith#
Throughout pregnancy, the human uterus shows a progressive
sensitivity to oxytocin in spite of rising progestrone
levels* This is in ©harp contrast with the rabbit
uterus, which became responsive only in the last few
days of pregnancy (Caapo, 19^1)# In 19f>6» Csapo evolved
the theory of a local progestrone block, upholding the
view that the effect of progestrone in human pregnancy
can be exercised by a local inhibitory effect on the
myometrium at the placental site# The block is raised
at term, allowing the onset of natural childbirth#
The possible physiological role of oxytocin in
. '
natural parturition is suggested by the following
evidences
1 There is complete analogy between normal
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spontaneous uterine contractions and uterine
motility elicited by oxytocin infusion,
appropriately administered in correct dosage.
This applies to the shape, intensity, frequency,
and tone as well as co-ordination of the con¬
tractions (C&ldeyro-Barcla and Poseiro, 1958).
Occurrence of milk-ejection in lactatlng women
(Ounther, 1948) and rabbits (Cross, 1958) with
each uterine contraction during labour. Similarly
Caldeyro-Bareia (1960) recorded the intra-mammary
duct pressure in women during labour, and reported
increased rhythmic activity implying release of
oxytocin.
Depletion of the oxytocin content of the neuro¬
hypophysis in various laboratory animals during
labour, again suggesting a rapid drain (Dicker
and Tyler, 1953; Acher and Promageot, 1957)*
The controversy as to whether or not labour was
retarded by hypophysectomy or section of the
pituitary stalk (Reviewed by Harris, 1955) has
largely lost its Interest, since it is now known
that oxytocin and vasopressin are produced in the
hypothalamic nuclei. These are now regarded as
part of the neurohypophysis as the posterior lobe
of the pituitary itself.
In spite of formidable difficulties in extracting
and assaying the small amounts of oxytocin in the
blood, Coch et al (1965) were able to demonstrate
increased plasma, oxytocic activity in blood
samples drav?n from the internal jugular veins
of women during labour. The findings are in line
with those on other mammalia. (Fitzpatrick, 19&1,
1965). |
It must be emphasised however* that the levels of
oxytocin found in jugular vein specimens (500 yUUnit/ml
plasma or more) are much higher than the theor tical
estimates of Oaomeli (1963) which are in the region of
3yixUnit/ml plasma. Again the high circulating levels of
the homone were only convincingly demonstrated in the
second stage of labour. The role of oxytocin in initiat¬
ing and maintaining first stage contractions ia thus ©till
questionable.
The release of oxytocin during labour may thus
correspond to Ferguson reflex (196-1) as shown in Fig. 6.
Dilatation of the cervix in post-partal rabbits stimulates
out-pouring of oxytocin from the neurohypophysis by
afferent nervous stimuli carried up th© spinal cord and
relayed through the hypothalamus. The reflex can be
abolished by spinal transection (T:7) and by cauterisation
of the jaituitary stalk.
2 OXYTOCIN Aid) LACTATION
Oxytocin causes contraction of the myoepithelial
Cells which surround the mammary alveoli and smaller ducts*
Preformed milk secretions are thus forced into the larger
Figure ii Reflex el case of Oxytocin as
Result of Cervical Dilatation (Ferguson
Reflex).
lactiferous ducts and sinuses, raising the intra-mammary
duct pressure and producing milk "let down" or "milk
ejection".
Experimentally, contraction of the alveoli can be
demonstrated following direct application of oxytocin
in vitro (Llnzell, 1939)* Strips of lactating mammary
tissue suspended in an organ bath contract on addition
of oxytocin (Mendcz-Dauer et al, 196(1). In vivo, intra¬
venous doses of oxytocin as small a® 1 mil• cause an
abrupt and transient rise in intraraarnmary duct pressure
in lactating rabbit (Van Dyke et al, 1955)» and in the
human female (Caldeyro-barcia, 1960). Sustained infusion
of oxytocin can produce rhythmic waves of increased
pressure (Caldeyro-Barcia, 1960). The pattern of
response simulates, but does not coincide with that of
the uterus.
Physiological release of oxytocin during lactation
in the human is evidenced by:
1 Milk-ejection from the contralateral breast
during breast feeding.
2 Increased uterine activity during suckling (Cobo
et al, 1965), and by mechanical stimulation of
the nipples at the end of pregnancy, during
labour or in the puerperiura (Lorand and Aebot,
1952). Clinically it is also commonly observed
that after-pains are commonly Initiated or
aggravated by breast feeding, presumably as a
result of colicky uterine contractions induced
Figure 5 Reflex Release of Oxytocin as a Result
or Mammary Stimulation (Milk- jectlon Reflex}#
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by circulating oxytocin.
The physiological stimulus for this milk "let down"
reflex is probably mechanical stimulation of the nipple
and areola during suckling (Fig. 5). The afferent side
of the reflex is nervousj the sensory stimuli being
relayed to the hypothalamic nuclei, which in turn induce
release of oxytocin from the neurohypophysis. This is
carried by the circulation to the breasts producing milk-
ejection. In this way, previously secreted milk stored
within the alveoli is made available for the suckling
offspring (galactoklnetic effect).
In addition to this direct milk-ejecting effect of
oxytocin on the lactating breast, oxytocin appears to
participate indirectly in promoting milk secretion by
the alveoli {galaetopoletic effect). Benson and Policy
(1957) have suggested that oxytocin released during
suckling stimulates release of prolactin (L.T.H.) from
the anterior lobe of the pituitary gland. They reported
that oxytocin injections could delay mammary involution
in nursing rats after removal of their litter. Ho such
effect was observed in hypophysectonised animals. This
view finds support in the work of Besclin (1956) and
Stunlsfcy (1957) who were able to induce pseudopregnancy
and formation of deciduomata in rats by oxytocin treatment.
Other workers (e.g. McCann et al, 1960) were unable to
confirm this finding. Thus at the moment, the galacto-
poietic function of oxytocin remains a possibility for
further investigation.
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3 RENAL EFFECTS OP OXYTOCIN AND VASOPRESSIN AND THEIR
POSSIBLE ROLE IN VJATF,R AND LECTROLYT% BALANCE OP
NORMAL AND TOXAEMIC PREGNANCY
The effects of vasopressin and oxytocin In water and
salt excretion by the kidney can be conveniently described
under the following items:
a Urine Volume Regulation
b Saluretic Responses
c Effects on Renal Haeraodymraies
Urine Volume Retaliation
There is general agreement that the neurohypophysis
is a main factor in the physiological regulation of the
rate of urine excretion. Experimental injury to the
neurohypophysis In the dog is followed by polyuria in the
post-operative period (Sehafer, 1909)• A similar finding
has been reported in many other species# In man, the
clinical syndrome of diabetes insipidus is Invariably
associated with lesions In the hypothalamic-neurohypophysial
tracts#
The antidiuretic effect of vasopressin Is best seen
during a phase of diuresis following Ingestion of a water
load* In man, vasopressin in doses of 0.25 - 0.5 mU/min#
is capable of Inhibiting ?<ater diuresis (Theobald, 1955)#
<K
The antidiuretic effect of vasopressin in mammals
is often accompanied by elevation of the osmotic concen¬
tration in the urine above the pla&ma levels. There Is,
however, evidence that the production of concentrated
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hyperosmotic urine is not directly dependent on the anti¬
diuretic response (Berliner and Davidson, 1957# Smith,1952).
The site of action of the antidiuretic hormone in
promoting water reabsorption from the glomerular filterate
has been convincingly shown in the mieropuneture experiments
of Wirg: (1957) to He In the distal convoluted tubules
and, poaibly, the collecting tubules. The exact mechanist
of action is not known. Morphological changes have been
observed in the intercellular substance between the
epithelial cells of the distal convoluted and collecting
tubules following administration of vasopressin (Ginctsin-
sfcy» 1958).
The antidiuretic response to vasopressin is influenced
by many factors including state of body hydration, the
concomittant administration of oxytocin, and the state
Df electrolyte balance. This topic has been reviewed by
lawyer (1961).
Saluretic Effects
Neurohypophysial extracts enhance Ha, K and chloride
axcretion in mammalian experimental animals. The occurr¬
ence and magnitude of saluresls depends on the peptides
injected, the species and the preexisting conditions of
salt and water loading. The effect can be produced by
oxytocin as well as vasopressin in rats receiving HaCl
infusion especially at low urine flow rates (Jacobson
|tnd Kellogg, 1956). When oxytocin salureais occurs in an
fcnimal that is already excreting a moderately concentrated
urine, the urine flow increases. This Is a well defined
2k
mechanism by which oxytocin can cause diuresis# In water
loaded animals* however* oxytocin produces a clear anti¬
diuretic response if sufficient doses are used# This
antidiuretic effect is reproducible in man in whom
saluretic responses have not been observed (Abdul-ICarim
and Assail* 195G)*
Action on Renal Kaemod.vnamics
Demuribrun et al (1954) reported depression of the
renal function in the dog following experimental Injury
to the neurohypophysis resulting in diabetes insipidus!
the effect was reversible by oxytocin administration#
Brooks and Plekford (i960) were unable to demonstrate
any depression of renal function with diabetes insipidus
in dogs# However* they reported that in dogs moderate
'
doses of oxytocin increase renal plasma flow, which
could be inhibited by small doses of vasopressin# The
role of oxytocin in the maintenance of renal function
thus remains a possibility for further investigation#
The role of the neurohypophysis in water and electro¬
lyte adjustments during normal pregnancy is not easy to
define# In spite of definite water* Ha and K retention
In pregnancy, there is little evidence that the release
of vasopressin* or the renal response to it are altered
in normal pregnancy# Hawker (1952) reported that an
antidiuretic substance (A#P.S#) was present in higher
levels in sera of pregnant women, and postulated that it
may account for some of the water retention during preg-
nancy# The assertion by several workers that water
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diuresis is impaired in late pregnancy (McManus et al,
1934? Theobald, 1934; Bieckmann, 1941) was challenged
by Theobald (1955)# who reinvestigated the problem and
£
came to the conclusion that the diuresis curves of the
non-pregnant and normal pregnant subject are substant¬
ially the same, Govan and Garrey (1964) and Kerr (1965)
emphasised the effect of posture on water diuresis in
late pregnancy# This provides a possible explanation
for the contradictory results of earlier works#
There is little information in the literature about
the pattern of the renal response to vasopressin in preg¬
nancy. Theobald (1934)^ found that the antidiuretic
response to a posterior pituitary extract was essentially
the same in pregnant and non-pregnant women. Assail et a"J
(1960) and Torres et al (1966) confirmed this finding,
but reported differences in the effects of vasopressin
injection on electrolyte excretion between pregnant and
non-pregnant subjects.
Pickford (1952) considered the water retention of
normal pregnancy as more likely to be secondary to salt
retention produced by placental steroids.
In contrast to the scanty information about the
neurohypophysial-kidney relationship in normal pregnancy,
there is a vast body of literature on the possible role
of the posterior pituitary gland in toxaemia of pregnancy#
Karlier workers were imp res ed by the potent vasopressor
and antidiuretic properties of posterior pituitary extracts
which could account for the hypertension and oliguria of
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6-
preeclampsia and eclampsia# Bof'oauer (1918, 1937)
postulated a pituitary adrenal mechanism as the cause of
e*
pr.eclampeia#
Antidiuretic and vasopressor substances have been
reported to be present in the sera of eclamptic women
by Anselmino and Hoffmann (1930, 1331# 1932) and
Mukherjee (1946)# Many other workers, however, failed
to demonstrate them (Byrom arid Wilson, 1934} Huroitz and
Bullock, 1935} Krieger and Kllvington, 1946; and Levitt#
1936)•
Similarly, there is a controversy on the presence
of antidiuretic substances in the urine of eclamptic and
preeclamptic patients and their nature (Tecl and Reid#
1939} Ham, 1341; Ham and Landls, 1942; and Krieger et al,
1951)* Peterson (1354) subjected the urine of normal
and toxaemlc patients to paper chromatography# He
discovered in all cases of eclampsia and in a majority
of cases of pregnancy hypertension, a urinary constituent
which occupied a position on the chromatograra identical
with that of the antidiuretic polypeptide described by
Amell and wilaon (1953)* In a subsequent publication,
Peterson (1961) confirmed his previous findings and
identified this substance by biological and chemical
studies to be allied to vasopressin#
The response of normal and toxaemic patients to the
administration of vasopressin was studied by Dieckmann
and Michel (1935» 1937); Shokacrt and Lambillon (1937)
and de Valera and Kellar (1938)# There is general
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e-
ttgreement that preeclamptic patients react more markedly
to injection of posterior pituitary extracts than normal
patients, aa evidenced by more pronounced hypertension
and oliguria* Browne (1946) further concluded that this
abnormal sensitivity to vasopressin was acquired after
mid-pregnancy in patients who were destined to develop
subsequent toxaemia*
Theobald (1955), reported that the administration of
P
vasopressin to hypertensive antenatal patients by intra¬
venous infusion resulted only in a transient hypertensive
response, and concluded that posterior pituitary hyper¬
activity could not account for the hypertension in
pregnancy*
h ADh'WUHY PQ FHYSIAL KX-KCTS Or POST RIOH PITUITARY HQRSOHlfe
Fopa and Fielding (1930) described a type of portal
circulation between the neurohypophysis and adenohypophysl
The capillary plexuses of the median eminence (which is
part of the neurohypophysis) collect into portal veins
which are redistributed into the anterior lobe ot the
pituitary gland (adenohypophysis)• heurohynophyeisl
products could thus reach the adenohypophysis in high
concentration and may contribute an important link in
the central nervous control over adenohypophysial
secretion (Fig* 6)«
Mention has been made of the possible effect of oxy*#




i-'lKure 6 Diagram of a Sagittal Section
through the Mammalian Hypothalamus and
Pituitary Gland to Demonstrate the Portal
Circulation between the Median Stalnenoe
(Neurohypophysis) and the Anterior Lobe
of the Pituitary Gland.
elicit corticotrophin release (Hume, 1958; Guillernin et al,
1959)* The doses required, however, are much higher than
those producing maximum antidiuresis (Mehols and. Guiliemin,
1959)* However, there la ample experimental evidence
to indicate a regulating action of the neurohypophysis on
anterior pituitary activity. Experiments involving
secretion of the pituitary gland (Harris, 1955) and pituiuaiy
transplantation (Kikit and Everett, 1958) indicate that
the anterior pituitary gland can only function normally
in the presence of direct vascular connections to the
neurohypophysis* Extracts of the median eminence and
pituitary stalk from several mammals were shown to contain
several "Trophin" releasing factors, including cartico-
trophin releasing factor (C.R.P.) (Saffran et al, 1955;
Schally and Bowers, 19&4), thyrotrophin releasing factor
(T.R.F.), lutelnising hormone releasing factor (L.R.F.)
(Guillemln, 1984) and possibly follicular stimulating
hormone and growth hormone releasing factors. The chemlenl
structure of these factors has not been identified, but
the available data suggested that they are relatively
simple polypeptides.
5 OXYTOCIN AND BP7M!E TRAdd PO RT
The possible role of oxytocin in sperm transport
has been reviewed by Fitzpatrick (1957)* who concluded,
that the rapid ascent of spermatozoa in the female genita.L
tract after mating is effected by uterine contractions
29
possibly due to release of oxytocin* Oxytocin has been
reported to increase the rate of ascent of sperms in
intact animals and in the isolated perfused uterus#
Oxytocin release during mating is also evidenced by
increased uterine activity and occurrence of milk efectior
in animals and man# Increased blood levels have been
reported in animals at the time of mating#
METABOLISM AKB PATS OF OXYTOCIN AIW VASOPRESSIN
Dale (1909) reported that Intravenous infections
of posterior pituitary extracts into cats resulted in the
excretion of a pressor substance in urine# Larson (1935)
found that the oxytocic as well as the pressor activity
of posterior pituitary extracts was eliminated by the
kidneys of anaesthetised cats and dogs, in amounts
varying between 12#8 to 37»7!$ of ^he infected doses#
| Similar findings were reported in other species (Heller,
1937; Larson, 1939; Ingram et al, 1939)* Gonzalez-Paniza
et al (1961) reported that 20^ of oxytocin administered
by intravenous infusion in non-pregnant female subfeet3
©as recovered in the urine# In pregnant women, only 1$
of the Infected doses was excreted# Aroskar et al (19&L)
employing synthetic oxytocin with a tritium labelled
leucine component, confirmed that following intravenous
infection In rats, only part of the radioactivity (30 -
35? ) 1® recovered in urine within a two hour period#
iany attempts at the elucidation of the fate of the
unexcreted portion of oxytocin and vasopressin have been
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made# Because of the great difficulties in assaying
"endogenous" levels of the hormones, various workers
investigated the fate of the hormones following injection
of the hormones in comparatively large doses in order to
achieve residual levels amenable to estimation by simple
biological assay methods. These experiments constitute
in vivo "clearance studies"• Alternatively, oxytocin
and vasopressin were incubated in vitro with various
tissue extracts. Such studies constitute in vitro
"inactivation" studies.
1 Clearance Studies
The studies of Oinsburg and Heller (1953) and
Gineburg and Smith (1959) indicate that exogenous vaso¬
pressin and oxytocin injected into rats are inactivated
principally by the kidneys and liver. If these are
excluded from the circulation, the rate of disappearance
of the hormones is markedly decreased. Similar findings
were reported in the dog (bauson and Bscanegra, 1960) and
rabbit (Chaudhury and Walker, 1959)* There are no
analogous data in human subjects, but there is no reason
to doubt that the liver and kidneys are the main sites
for clearance (and probably inactivation) of oxytocin and
vasopressin from the circulation. It has been suggested
that impaired water diuresis, oedema and ascites in
patients with liver cirrhosis are due partly to decreased
Inactivation by the diseased liver. (Rail1 ot al, 19U5)•
The rate of clearance of injected oxytocin and vaso¬
pressin from the circulation of several laboratory animals
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as mil as the human haa been Investigated* "Half-life"
values are interpolated from assay of the hormones on
serial blood samples. The results obtained in various
species are shown In Table 3# The results appear
anomalous when compared to the duration of the effects
of oxytocin and vasopressin on the target organs* In
women near to term, the half life of the uterine effects
of oxytocin infusions was calculated by 3ica-Blanco and
*
Sala (1961) as 15 minutes* Similarly, the antidiuretic
effect of vasopressin on the kidney lasts 20-30 minutes
or longer (de hardener, 1957).
2 In Vitro Imotivation Studies
The finding that only a minor proportion of injected
oxytocin and vasopressin can be recovered in a biologically
active form has stimulated research on the possible
inactivation of the hormones by various tissue extracts*
Enzymatic inactivation of both polypeptides has been
reported following their incubation with various tissue
extracts* Such enzymes are commonly referred to as
"tissue oxytocinase" and "tissue vasopreaslnsee". 4s
pointed out by Heller (1957) the specifity of these
enzymes is not yet established, and it is hardly just¬
ifiable to give them such labels* All the more, since,
in vitro, oxytocin and vasopressin can be inactivated
by several known mammalian enzymes, e*g* chymotrypsin,
spleen aminopeptidase and kidney hypertensinase
(Croxatto et al, 19^2)# Vasopressin is also inactivated
by trypsin (hawler and Bu Vigneaud, 19535#







Oinsburgand Heller,1933 Ghaudhurynd talker,1959 Schroderand Rott,1959
Oxytocin
OxytocicEffe tonIsolatedRat' Uterus
Rat Habbit Sheep Human" Male Pregnant FemaleMilk-ejectingffe t
1.6Ginsburgand Smith,1959 3Chaudhurynd Walker,1959 /1Fitzpotrick, 1961 <1'itzpatrick, 1961 3Gcnzalez- Panizza,etl, 1961
Half-LifeClearancV luesoOxytocinndasopressin
33
Experiments with suspensions and homogenates of
organs of various laboratory animals showed some loss of anti¬
diuretic, pressor or oxytocic activity in all Instances
(Heller and Urban, 1935J Larson, 1938; Bimie, 1953;
Sawyer, 195L5* The highest activity appeared to be in
liver and kidney homogenates. Werie (1960) compared the
responsible enzymes in various tissue extracts, revealing
differences in pK activity ranges, and in their sensitivity
to various inhibitor systems.
Ginsburg and Smith (1959) noted rapid in vivo clear¬
ance of oxytocin from the circulation in lactating rats,
and suggested that significant elimination of oxytocin
occurred in the mammary glands. Sawyer (195L) reported
that homogenatea of myometrium from pregnant or pseudo-
pregnant rats destroyed oxytocin at rates comparable
to the rates of Inactivation by liver or kldney3. By
i
contrast, in the rabbit uterus, the oxytocin inactivating
enzyme(s) decreases during pregnancy and is minimal at
term (Bicker and Whyley, 1960). Ho such activity could
be demonstrated in the myometrium from several women near
to term. Hawker (1956) reported inactivation of oxytocin
and vaeopreasin following incubation with extracts of
human placentae. Placentae of cases of preeclampsia had
less activity per unit weight than those of normal
pregnancy.
Hooper and Jesaup (1959) and Hooper (1959) further
studied "Oxytocinase" and "Vasopressinaae" in extracts
of human placentae. They reported that the two activities
3k
are separable by ultracentrifugation. Cxytocinase
remained in the supernatant, while vasopresr inaae was
associated with mitochondrial and microsomal fractions.
The two systems also had different pH optima and behaved
0
differently towards organphosphorus inhibitors.
The role of these various tissue oxytocin and
vasopressin inactivating systems in the physiological
metabolism of the hormones is not known. However, the
work of Aroskar et al (19&4) sug ested that radioactive
labelled oxytocin was widely distributed in the tissues
within a short time after their intravenous infection.
There it could possibly come under the effect of these
various inactivating systems.
Rycbllk (19^4) reported a biochemical study on the
mechanism of enzymatic degradation of oxytocin by a liver
extract, employing paper chromatography, to identify the
reaction products. He concluded that inactivation occurs
in two steps. First, a reduction of the disulphide
bond (position 1-6) occurred by a transhydrogenase
,
enzyme. The reaction was greatly enhanced in presence of
reduced glutathione and was probably reversible. In the
second step, the open chain dihydro compound was affected
by an aminopeptidase which did not attack the Intact
hormone itself. Fission occurred at the "cysteine" -
tyrosine bond (1 - 2),and on longer incubation the rest
of the molecule was systematically degraded.
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PR SOTtANOY SERUM OXYTOCIKAGS |
a Early Observations
In 1930, Feket© was first to observe that the serum
of pregnant women is able to inactivate the oxytocic
properties of posterior pituitary extracts# In a sub¬
sequent publication (1932) he asserted that this property
of sera became mo re pronounced as pregnancy advanced#
The lose of oxytocic activity was demonstrated on a prep¬
aration of isolated guinea pig uterus#
Shortly afterwards, Plctel (1933) reported the
presence of a substance antagonistic to the antidiuretic
effects of pituitary extracts in sera of pregnant women.
SchocKoert and Lambillon in 1935 observed a similar loss
of vasopressor activity of pituitary extracts incubated
with pregnancy sera.
b Studies on Pregnancy Borum Qxytocinasc by
Biological Assay Methods
erle and Sffkemann (19h15 employed the isolated
rat uterus preparation to assay the residual oxytocin
following incubation with pregnancy sera# They were the
first to establish that the biological inactivation of
oxytocin by late pregnancy sera is an enzymatic process#
In 19h1, Wepie et al# found that the enzyme was only
present in pregnancy sera, but was absent from sera of men
and non-pregnant women. Ho activity was found in foetal
cord blood, and thus they concluded that the enzyme did
not cross the placental barrier# Moreover, Werle and co-
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workers (19M) observed that the enzymatie activity in
pregnancy sera was stable at room temperature, and was
not reduced by storage at k°C for one month. The
activity wae destroyed toy boiling, but remained unaffectec
by dialysis against water for 2k hours. The maximal
activity was found at a pH ranging from 6.5 to 7.5.
Serum and plasma samples from the same subjects had
identical activities.
Page (19^6) made a similar study of the enzyme in
pregnancy plasma and labelled it "Pitocinase"• This
name was later severely criticised by Heller (1957)* Paga
(19<U6) reported that the kinetics of the enzymatic reaction
under his conditions of incubation followed a first order
reaction, and proposed a unit for enzyme activity based
on the velocity constant. His finding, as regards
stability and distribution of the enzyme in human preg¬
nancy confirmed the work by Werle et al (1941). Page
(I9h6) reported a progress ive rise of the enzyme levels
throughout pregnancy amounting to a thousandfold at term.
Knzyme levels in cases of twins and intrauterine foetal
death did not vary from the normal range. Pitocinase
activity was found in high concentration in human placental
extracts and In suspensions of haemolysed red blood cells,
but was absent from sera of guinea pig, rabbit and rat.
In 19h7» Page suggested the use of pitocinase estimations
as a pregnancy test and as a method for assessing the
gestational age.
&erle et al (1950) studied the distribution of
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oxytocinaee in blood of various mammalian species. No
enzymatic activity wan found in the sera of horses,
sheep, dogs, guinea pigs or rato, whether in the pregnant
or non-pregnant state# Oxytocin-aplitting enzymes were
found only in the sera of pregnant women and apes. In
1951, Werle and Seram investigated the changes in enzyme
levels throughout pregnancy. The enzyme was detectable
by the h6th day of pregnancy, with rising levels in the
second and third months of pregnancy. It remained at
roughly the same levels from the third to the eighth
month of gestation, and then began to rise again until
at labour it reached a level sixty times higher than the
levels at the end of the second month.
Subsequently (1936) Werle and Semin studied the effec
of various inhibitors on pregnancy serum oxytocinaae and
reported inhibition by the metal-chelating agents E.D.T.A.
and 8-Hydroxy~quinoline, which could be reversed by
<§*4" 44 44
adding Co , Mn or 2n • They also investigated the
distribution of oxytocinaae in the various protein
fractions of pregnancy sera. In vertical continuous
electrophoresis the enzymatic activity was found in the
cathode side of the albumin fraction and in the <k.
1
globulin fraction.
Werle (1960) compared the properties of oxytocin
splitting enzymes systems in various tissue extracts with
those of pregnancy serum oxytocinaae, and pointed out the
following differences:
&
a Pregnancy scram oxytocinase la more stable than
"tissue oxytocinase".
b The serum enzyme Is inhibited by metal-chelating
agents, whereas the activity of the tissue
enzymes is unaffected by those inhibitors. He
thus concluded that serum and tissue oxytocinase
are probably different enzyme systems.
Aragon (19U8) and Woodbury et al (19^8) Investigated
the enzyme levels in toxoemic patients, and were unable
to demonstrate any significant differences from a normal
control group. Both workers concluded that the hyper¬
sensitivity of preeclamptic and eclamptic patients to
posterior pituitary hormones could not be attributed to
diminished ability of the blood to inactivate them.
Bicker and Tyler (1956) Investigated the enzyme
levels for a possible drop at the time of onset of
spontaneous labour which could be a causative factor In
initiating normal labour at term. They reported that the
ability of pregnancy sera to inactivate oxytocin decreased
from the 28th week onwards, and could not be detected at
term in the majority of cases. This finding was confirmed
by Hilton and Johnson (1959)* Bicker and Whyley (1959)
reinvestigated the problem with a better controlled
incubation technique and a h-polnt biological assay on
the isolated rat uterus. They found that the inactivotion
of oxytocin by pregnancy plasma reaches a maximal plateau
in the last k weeks of pregnancy, with no drop during
labour. The enzyme levels bore no relationship to the
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occurrence of toxaemia in pregnancy or uterine inertia
in labour#
Mendez-Bauer et al (1961) carried out a well
controlled study of pregnancy plasma oxytoeinane, assay¬
ing the residual oxytocin after incubation on the lactat-
ing mammary glands of rabbits (which is a more specific
test organ for oxytocin)# Plasma (9 volumes) was
incubated with synthetic oxytocin (1 volume)# The initial
part of the reaction followed a first order pattern and
the reciprocal of the half-time life was used as a
measure of enzyme activity# They demonstrated a tenfold
Increase in the enzyme level by the end of gestation,
with no drop before or at the time of onset of labour#
Parallel studies on pregnancy serum "vasopresainase"
were carried out by Werle and Kctlvelage (19415; Vioodbury
et al (1948); Meekrriann et al (1950); McCartney et al
(1952); Croxatto et al (1953) and Barnes and Sawyer (1960
Following incubation of vasopressin with pregnancy sera,
plasma or whole blood, the residual activity was assayed
by its vasopressor or antidiuretic effects# The results
indicated an increase of vasopreskinase activity in
pregnancy, with no difference between normal and toxemic
subjects# The enzyme was not detectable in foetal cord
blood and disappeared slowly from the maternal circulation
after delivery#
Pieckmann et al (1950) and Croxatto et al (1953)
suggested that the same enzyme may be involved in the
inactivation of both oxytocin and vasopressin, but gave
ko
little direct evidence for this view* Werle (1960) on
the other hand, suggested that pregnancy serum oxytocinase
and vasopressins© are different enzyme systems. His
argument is based on the finding that non-pregnancy sera
also show a substantial vasopres inase activity. Further¬
more, D.T.A. has no effect on pregnancy serum vaso-
prearinaee in contrast to its strong inhibitory effect on
ox;/toe inase.
c Biochemical studies on Pregnancy Berum
0>:y toe inase
Biochemical studies on pregnancy serum oxytocinase
only became possible after the molecular structure of the
hormone was identified and pure synthetic preparations
became available.
Tuppy and Nesvadba (1957) incubated oxytocin with
serum of women in advanced pregnancy until the uterotonic
effect of the hormone was lost. The incubation mixture
was deproteinised with trichloracetic acid and the
degradation product of oxytocin was oxidised with perform!
acid. Paper chromatography at this stage revealed the
presence of free eysteic acid in addition to a polypeptide
containing cysteic acid, tyrosine, ieoleucine, glutaminr,
aspargine, proline, leucine and glycine. By comparison,
oxidation of pure oxytocin yields a single polypeptide,
with no free cysteic acid (Mueller et al, 1951). Tuppy
and Nesvadba thus concluded pregnancy serum oxytocinase
cleaves the oxytocin molecule at the peptide bond linking
the tyrosine residue (position 2) to the terminal half-
U1
cystine residue (position 1) which carries a free amino
group.
Proposed site of action of pregnancy serum
i
Cys-Tyr-I.leuc.-Glu (N.H. 2)-Asp (NH2)-Cys-Pro.Leuc.Gly.(HE
—?
Site of action of performic acid
The pregnancy serum enzyme thus appeared to be a
proteolytic enzyme which acted as an arninopeptidase.
To test the validity of this concept, Tuppy and
Nesvadba (1957) compared the aminopeptidase activities
of pregnancy and non-pregnancy sera, employing the syn¬
thetic ^-naphthylamide compounds of leucine, alanine and
glycine. In presence of arainopeptidases, these compounds
are split with the release of ^-naphthylamine which can
be measured colorimetrically. All these ft-naphthylamide
compounds were found to be readily split by non-pregnancy
sera. In late pregnancy the splitting potency of the
sera was enhanced by a factor of not more than 3«5« Con¬
sidering the published data on oxytocinase which indicated
its absence in non-pregnancy sera and a much greater rise
during pregnancy, they concluded that the enzymes respon-
ible for the cleavage of these 3 amino-acid ^- naphthy¬
lamide compounds could not be identical with oxytocinase.
Tuppy and Nesvadba (1957) next investigated the
possibility that oxytocinase is a specific aminopeptidase
acting on sfcbstrates which, like oxytocin, possess amino-
terminal half cystine residues. For this purpose, they
synthesised and tested a new substrate: L-Cystine-di-ft -
naphthylamide# /hen incubated with different sera this
aminopeptidase substrate showed a pattern similar to oxy¬
tocin# Thus it was readily split by the sera of pregnant
women, but only very slightly by sera of men and non¬
pregnant women# Thus they postulated that oxytocinase is
a specific aminojjeptldase which acts on compounds carrying
half terminal amino groups, and that the synthetic
substrate L-Cystine-di-^ -naphthylarnide,which carries a
similar bond, can be employed for the enzyme assay#
To test the validity of this conclusion, Tuppy and
Wintersberger (1961) carried out a stepwise purification
of the enzyme, using retroplacental serum as a starting
material. Purification involved ammonium sulphate
precipitation, absorption on bentonite, and repeated
column chromatography# The specific activity was deter¬
mined at the various stages and an overall U500 fold
purification was achieved# The properties of the purif¬
ies sample were examined and conformed, with the published,
data on oxytocinase assayed biologically. In addition,
the purification products of the various steps were
tested by Stoklaska and 8intersberger (1959) for their
aminopeptidase activity as determined with the synthetic
L-Cystine-di-^ -naphthylamide substrate, and for their
oxytocin inactivating potency as assayed by residual
activity on the isolated rat uterus# Throughout the
process of fractionation, the two activities proved
inseparable; they retained the same unchanged ratio, and
showed identical pattern of rise in specific activity.
U3
Aim of the Present dtud.v
This study is concerned with throwing light on the
following aspects of the problems
1 Assessment of the primary site of action of the
pregnancy serum ©nzyme(s) on the oxytocin and
vasopressin moleeules. i.e. of the identity of
.
pregnancy serum oxytocinase and vasopresslnase.
2 Evaluation of the chemical methods for estimation
,
of pregnancy serum oxytocinase.
3 Study of the distribution of the enzyme in the
sera of women in normal and abnormal pregnancy.
k Investigation of the site of origin of pregnancy









Unless otherwise stated, all chemicals used in this




The following buffers were employed -
a Phosphate Buffers
Phosphate buffers were prepared from crystalline
Sodium Monohydrogen Phosphate (Ha^feU PC^.12H2Q,
Mol. Wt. 358.22) and Sodium Pihydrogen Phosphate
(NaH2 P0^-2H20 III, Wt. 156.03}# Stock solutions
of both salts were prepared in an ionic strength
0.2 M. The final buffers were obtained by mixing
the two solutions in the following proportionst
Na2HP0^ HaHgPO^
pH 7.4 M 9.2 61.0 19.0
pH 8.0 M 0.2 94.7 5.3
Veronal Buffer (pH 7.9) M 0.046
68.9 ail. of 0.1M sodium barbitone (20.6 gm.
sodium diethyl-barbiturate per litre of boiled
carbon-dioxide free distilled water) is mixed
with 31.1 ml. of o.1 N HC1 and 50 ml. distilled
water.
c Trie, buffer (pH 7.9) M 0.1
Y
A stock solution of 0.4 M Tris. (Hydroxmethyl)
amino-methane (Mol. At. 121.14) was prepared
45
(1+8.46 gnu per litre of distilled water) • The
"buffer was then obtained by mixing 25 ml. of
this solution with 32.5 ml. G«2 N HC1 and diluted
to 100 ml. with distilled water.
The pH of all buffers was checked by the glass
electrode and the solutions were stored at 4°C.
3 pH Measurements
henever possible, pH measurements were performed
on a Pye-Cambridge glass electrode pH meter. Occasionally,
with small volumes, approximate readings were obtained
by using B.B.H. pH paper strips.
4 Spectrophotometric and PXuorimetrie Estimations
All reactions which required fluorimetric or spec tro-*
photometric estimations were carried out in duplicate
tubes with a blank and a standard for each experiment.
spectrophotometrie estimations were carried out in a
Unlearn Sp. 600 using rectangular 10 m.ro. cuvettes. The
blanks (or zero time controls) were set to zero and the
readings for the standard and unknown solutions were
registered as optical densities (O.D.)•
Fluorimetrie estimations were done in a bocarte
single sided Fluorimeter MK 4» using cylindrical cuvettes
10 num. in diameter. Blanks wore set to zero and the
high standard was set at 100. The fluorescence of the
unkmrnn solutions was read a© percentage of the high




Arithmetic means were compared by Student t test at
a minimal significance level of P 0*05#
Standard deviation in small samples ( <( 10} was
computed from the ranges (Oaddum, 19533)#
Statistical analysis of the biological 4-point
assays of oxytocin on rat uterus was carried out by the
simplified methods of Noel (1945)# The following
symbols were employeds
N Number of sets of observations
Sj and Sg Effects of low and high doses
of the standard
Uj and Ug Effects of low and high doses
of the unknown
I Log# ratio of doses
M Log* ratio 0/3
3 Summation sign
s Standard deviation of a single
observation
b Estimate of slope
R % potency U/S
Index of precision
ft
. Standard error of R
6 Collection and Storage of Blood Samples
Maternal blood samples were obtained from the arm
veins# Haemolysis was avoided by emptying the syringe
slowly and refraining from forcibly expelling any residual
U7
froth. Heparlnised plasma was used with the biological
method for enzyme aasay, otherwise sera were employed.
In all cases serum (or plasma) was separated by spinning
the blood sample at 2000 r.p.m. for 10 minutes within
two hours from collection. The serum (or plasma) was
decanted and stored at U°C» Enzymatic estimations were
always carried out within 1*8 hours from collection.
Foetal blood samples were obtained from full time
infants, at the time of delivery, by milking the umbilical
cord. No attempt was made to secure venous and arterial
blood samples separately.
Uterine vein blood samples were obtained from
patients undergoing lower segment Caesarean Section near
to term. After the peritoneum of the utero-vesical pouch
was opened, the main stem of the uterine vein was exposed
at the side of the uterus, and a blood sample was aspirated.
Blood samples from small animals (rat and mouse)
were obtained by decapitation. Blood samples from cow,





A QSSS&MSI11 SUM 92, pri'XH.AKCY P ASMA AKD PLAC KNTAL
PXYTOCIHASS ACTIVITY BY A BIOLOGICAL ASSAY :,I THOD
Although a placental origin of pregnancy plasma oxy-
tocinase has been suggested by Page (19M>)> Carballo and
Mendez-Bauer (1957) and Santa (19&1)» Inhibitor studies
seem to indicate differences in the properties of the
two enzyme systems# $erle and Semen (195&) reported that
the serum enzyme is inhibited by metal chelating agents
such as F.D.T.A. Placental oxytocinase on the other hand|
was reported to be unaffected by 15#I>#T, A. (Hooper, 1959)#
Hooper (1959) however, stated that it is possible that
Inhibitors ineffective under his experimental conditions
may be effective at a different pK or with a longer contact
time*
As the experimental conditions differed in the two
reports, this study was undertaken to investigate the
inhibitor spectra of the plasma and placental oxytocinase
activities under similar conditions#
BIOBQGICAL rfKTHOi) PGR ASSAY OF O.YTOCINASK
The essential part of this method is the biological
assay of residual oxytocin following incubation with
placental extracts or pregnancy plasma under suitable
conditions#
For this purpose, isolated rat uterus was employed
according to the method of Holton (1948)# Although more
sensitive methods are available (Table 1) for the assay
of oxytocin, this method is sensitive enough for the
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present stud;/. It is also quick and has good precision,
(X) Assay of Oxytocin on the Isolated Rat Uterus
For this purpose mature female rats weighing 160-
200 gnu were selected and prepared by a subcutaneous
injection of a dose of 20 pgm. of etilboestrol in arachis
oil 16 - 24 hours before the actual assay. This dose of
stilboestrol induced oestrus in the rat with attendant
changes in the uterine horns which became oedematcus,
hypertrophic and more sensitive to oxytocin (Gaddum and
Kameed, 1954)* It has also been ahown that in proeetrus
and oestrus the rat uterus has least spontaneous activity,
and this is a desirable feature in oxytocin assay (Flat let
1954)* Although suitable animals can equally be selected
by daily vaginal smears (Flatters, 1954) pretreatment
with an oestrogenic substance obviated the need for main¬
taining a large colony of animals.
The chosen animal was killed by a sharp jerk to the
neck, producing dislocation of the cervical spine. The
two uterine horns were dissected out. One horn was used
for the actual assay. The other horn was stored at 4 G
in the solution described by Be Jalon and Be Jalon (1945)
and could be used satisfactorily within 1 to 2 days.
The cervical part of the horn was used for the assay
as it has less spontaneous activity than the ovarian end
(Werle and Semm, 1951)» About 2 cm. length was secured
from the cervical end of the horn and suspended in the
tissue chamber (2 ml. capacity) of an organ bath. The
lower end of the horn was fixed to a metal hook, and the
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upper end was attached by thread to the short arts of a
frontal writing level# The tissue chamber was lowered
into the organ bath and was filled up with a modified
Locke's solution of the following composition*
Glass distilled water 1000 ml
The ingredients were prepared in concentrated stock
solutions and stored at L°C# The final solution was
freshly prepared every 2-3 days, in one litre amounts#
Compared to Locke's solution, this medium has a reduced
calcium and glucose content {& and & respectively). As
reported by Be Jalon and Be Jalon (19L5)» this medium
reduces the spontaneous activity of the rat's uterus#
The bathing fluid was led into the bottom of the tissue
chamber through a glass coil immersed in the surrounding
water bath, the temperature of which was maintained at 29°C
(£ 0.5) by means of a thermostat# The tissue chamber was
aerated by a uniform current of a mixture of % CO- ind
95f- oxygen bubbled into the base of the chamber through
a fine hypodermic needle#
Recording of uterine contractions was obtained by
a frontal writing lever on a smoked drum# A load of 1.2 -
1*5 gm# was applied on the uterine side of the lever,
which had a magnification of 1*6#
Following suspension of the horn in the organ bath,
the preparation was left to equilibrate for half an hour






with frequent changing of the bathing fluid# before the
actual assay was begun#
Doses of standard oxytocin solution were then added
to the bath by a blow-out pipette to determine the range
of sensitivity of the preparation. Contractions usually
occurred within 30 seconds after an effective dose. After
the peak of the contraction had been recorded and the
lever was steadily going down# the tissue chamber was
drained and washed out twice with bathing fluid and flnall,
refilled. The subsequent dose was added exactly 3 minutes
after return of the lever to the base line, and the whole
procedure was repeated. Once the response of the prep¬
aration to the standard oxytocin solution became stabilised
assay of the oxytocin potency of the unknown solution was
carried out by one of two methods,
a - Bracketing
Two dose levels of standard were given before and
after two dose levels of the unknown, the unknown being
diluted until responses were approximately equal to those
of the standard. This method gave an approximate estimate
i>f the oxytocin content of the unknown, but no reliable
estimate of the error of the assay. It was used in the
preliminary studies on oxytocinase#
b - Four-point assay method (3child, 191*2)
Two doses of the standard solution (3^ and Sg) were
'ound out by trial and error which resulted in contractions
Approximately 3QT and 8Q& of the maximum. The ratio between
uhe two doses varied in different preparations, but usually
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lay between 1s2 and 3*U» At the same time, two doses
of the unknown solution (U^ and 0,,) were chosen to give
contractions of approximately the same heights as the
standard# For the final statistical analysis the ratio
U^/Ug should be the same as S^/Sg# The four selected
doses were subsequently administered in a random order,
the whole procedure being repeated 3 to 5 times, using
a different random order of doses each time# The total
assay thus comprised 12 - 20 contractions, and was usually
completed in if to 2§ hours. A suitable preparation
could usually be used for two successive assays# The
smoked paper was then varnished and hung up to dry#
This method allowed a more accurate determination
of the strength of the unknown solution, as well as an
estimate of the range of error#
Fig# ? represents a complete h-point assay#
The statistical treatment of the data was performed
according to the simplified method described by Noel (1949)
and Gaddum and Lembeck (1945)• The data are shown for
the same experiment in Table
(IX) Conditions for Incubation
,
In order to compare the effects of various inhibitors
on pregnaney plasma and placental oxytocinase, it was
necessary to investigate certain aspects of the enzyme
kinetics and establish standard conditions for incubation
suitable for measuring inhibition# For this purpose, the
Fifliire 2 iHPoint Assay of oxytocin on. the Isolated fiat Utcme.
























Calculations for the Assay shown in Fig. 6















Log. Ratio of Doses
T1 I/T2
100 Anti Log. M
Tg/2 IN
S(Y1)2 + S(Y2)2 + S(Y3):
rr. 2 2 m 2
1 2 + 3
y(A~B/N) /12 (N -I)
s/b
/(1*- T^/Tg2) /'N
2.3 x /M x R
T^/23 \flT~
1 2 3 2+
30 22 21 17
51 2+7 30 2+3
22* 20 18 18
50 2*2 2+2* 2*5
- 1 - 5 +12+ 2
- 6 - 2 - 3 - 1
26 22 26 27
21 25 9 26
- 7 - 7 11 3
2*7 47 35 53






























Oxytocin content of unknown is
The unknown therefore contains
100% (1 5*8) that of standard.
6 or 15 m.u/ml. (- 0.9)
0.2*
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enzymatic activity in late pregnancy plasma or placental
extract rae estimated, by incubation with synthetic oxytocin
(Syntocinon, Gandoz) in presence of phosphate buffer
(pB 7*4* ionic strength 0*2 &}• The concentration of
i oxytocin was standardised at 1 Unit/ml. of the Incubation
mixture, and the following aspects of the enzyme kinetics
were Investigated*
1 Time course of enzymatic inactivation (Progress
Curve)
2 Effect of varying enzyme concentrations
3 Stability of the enzymes
("1) Progress Curve
Two mis of plasma from subjects 36 to 40 weeks
pregnant were incubated with 20 U of oxytocin (2 mla.),
and the final volume was brought up to 20 mis* with
phosphate buffer* Immediately after mixing, a 5 ml*
sample was pipet ted off into a separate tube and dipped
into a boiling water bath for $ minutes and served as
zero time control* The remaining part of the mixture was
incubated in a water bath at 37°G* Specimens were with¬
drawn at various time intervals and dipped into a boiling
water bath for 5 minutes to stop the enzymatic reaction-
After cooling, all specimens were filtered* The residual
oxytocin was assayed by the bracketing technique on
isolated rat uterus, using the zero time control specimens
as a standard*
The experiment was repeated with 3 different plasma
samples from women in late pregnancy* The results are
shown in Fig. 8. The enzymatic inactivation appears to
follow a first order reaction. This finding is in agree¬
ment with the reports of Werle et al Page (1946);
and Dicker and Lhyley (1959)« Approximately JO - 50^ of
oxytocin in the incubation mixture was inactivated in 10
minutes, and 73 ~ 90; in 60 minutes. A similar finding
has been reported by Dicker and Whyley (1959)* According!^,
under these conditions of incubation, the relationship
between Log percentage residxial oxytocin and tine (in
minutes) is approximately linear with a negative slope
(Fig. 9).
(2) iOfi'ect of Varying the Enzyme Concentration
(a) Plasma Oxyfcocinase
Varying volumes of late pregnancy plasma (0.1 - 2 ml
were incubated for 60 minutes with 10 U oxytocin in a final,
volume of 10 ml. phosphate buffer. The reaction was then
stopped by heat and the residual oxytocin assayed toy the
bracketing technique. The results obtained with 3 dif fereii
plasma specimens are shown in Table 3. In Pig. 10 the
plasma volume in the incubation mixture is plotted against
uog percentage residual oxytocin. The relationship is
approximately linear with a negative slope within the range
0.1 to 1 ml. plasma/10 ml. incubation mixture. Employing
n concentration of 1 ml. of late pregnancy plasma in 10 ml.
Incubation mixture, differences in Log percentage residual
oxytocin after one hour incubation could thus be accepted
as a measure of enzymatic activity.
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ml. Plaana/10 ml. Incubation Mixture
„ 0.2 0.6 0.6 0.8 1.0 1.5 2.0
66 40 22.5 - 10 <2
g£ 66 6o 30 - 12.5 <5
tKO 80 50 - 60 25 9 5
Percentage Residual Oxytocin after 60 minutes Incu¬
bation with Various Volumes of 3 Different Plasma
Samples of Subjects at 36-60 'Seeks of Pregnancy
TABLE 6
ml. Placental SIxtract/10 ml. Incubation Mixture
























Percentage Residual Oxytocin after 60 minutes Incu¬
bation with Various Volumes of 3 Different Placental
Extracts in Online 1:1 (wt/v.)
Figure 8 Time Course Relationship of Oxy¬
tocin Inactivatlon by Plasma of Women In
Late Pregnancy.
Residual Oxytocin %
Figure 2 Progress Curve of Oxytocin
Inactlvation by Plasma of women In
Late Pi'egnancy. Logarithmic Scale on
the Ordinate#
Residual Oxytocin %
lOml. of Incubation Mixture.
Figure 10 Relationship between Changes in
Plasma Concentration end OxytocinsBe Act¬
ivity (Expressed as Log. Percentage Resid¬




Extracts of full term placentae were prepared
according to the method described by Hawker (1956). Presi
placentae from cases of normal delivery were extracted
within 12 hours. The membranes were stripped off and all
adherent clots were washed off under a current of tap
water. Pieces of tissue approximately 5 m.m. thick were
sliced off the maternal surface and floated for 10 minutes
in a basin containing tap water to free them from blood.
The tissue slices were then blotted between filter paper.
Twenty grams of tissue were then weighed and mixed with
20 ml. of 0.9? EaCl solution and a suitable quantity of
silver sand in a porcelain mortar, and then thoroughly
homogenised for 20 minutes by the pestle. The homogenate
was then centrifuged at 3000 r.p.m. for 15 minutes. The
supernatant was decanted and employed as a source of
placental oxytoclnase.
Various volumes of the extract (0.1 - 2 ml.) were
incubated with oxytocin (10 U), the final volume being
brought to 10 ml. with phosphate buffer. A zero time
specimen was secured and deproteinised by heat. At the
end of 60 minutes incubation, the test mixture was treated
similarly. The solutions were cooled and filtered. The
residual oxytocin in the test mixture was assayed, using
the zero time control as standard. The results with 3
different extracts are shown in Table 6 and Pig. 11.
The enzymatic activity of O.U to 0.5 ml. of the
placental extracts was found approximately equivalent to
Residual Oxytocin %
in lOml of Incubation Mixture.
Pjgure 11 Relationship between Changes
in Placental Extract Concentration and
Oxytoeinase Activity {Expressed as Cog*
Percentage Residual Oxytocin after Incu¬
bation for 60 Minutes)*
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one ml. or late pregnancy plasma, producing inactivation
of 80 to 9Q£ of oxytocin in 60 minutes under the present
experimental conditions. In the range of 0.1 to 0.4 ml.
of placental extract per 10 ml. of incubation mixture,
Log percentage residual oxytocin showed a linear negative
correlation with the concentration of placental extract
in the mixture (with a negative slope) (Pig. 11).
(3) stability of the Knzymea
Plasma samples (one ml.) were assayed for oxytocinasa
activity as before on the day of collection. The remaining
part of the plasma ©ample was stored at 4°C. estimations
were repeated 24 hours and 48 hours later. Comparable
Inactivation of oxytocin was obtained with all 3 specimens
indicating no lotss of activity with storage. 1'he exper¬
iment was repeated with two different placental extracts
(using 0.4 ml. of extract) with similar results.
(Ill) Inhibitor Studies
Pop a comparative study of the effect of various
enzyme inhibitors on oxytocinase activity in pregnancy
plasma and placental extracts, the conditions for incubation
were standardised as follows*
Plasma from women 36-40 weeks pregnant 1.0 ml.
(or placental extract) (0.4 ml.)
Oxytocin (Syntocinln) 10 Units
Phosphate Buffer (M 0.2, pH 74) ad. 10 ml.
A zero time sample (4 ml.) was pipetted off into a
s<{
sejjarate tube after mixing, and deproteinised by dipping
in a boiling renter bath for 5 minutes. The remaining
part of the mixture was incubated for one hour at 37°0
(- 0.5) in a water bath, and then similarly deproteinised
by heat. For inhibition experiments, the plasma (or
placental extract) ?ms Incubated with an equal volume of
the inhibitor solution for 15 minutes at 37°C» All
inhibitors were added in aqueous solution containing
2 x 10"""3M, thus securing a final concentration of 1Q~3M.
Th© only exception was tV.T.A. (Ethylene Biamine-Tetra-
Acetate), where a concentration of 1Q~2:. was employed as
In Werle's work (19&0).
Following preliminary incubation with an Inhibitor,
th© other ingredients of the incubation mixture (oxytocin
■
10 0 and phosphate buffer, ad 10 ml,) were added. A
sero time sample was pipetted off and the experiment pro¬
ceeded exactly as with the control tubes.
The effect of the following inhibitors was investigated:
(1) Heavy Metals
Cu"f+ 10~3| (as Cu 30^. 5 Hg0)
2n++ 10~3M (as Zn 30^* 7 HgO)
Ag* 10~* (as Ag NO,)J5
Ve+* 10"* (as Fe SQ^)
(ii) Metal Chelating Agents






p. Chlormercuric benzoate (sodium salt)
All relatione were cooled to room temperature and
filtered before assaying the residual oxytocin content by
the L-point technique against the corresponding zero time
sample. In addition, the oxytocin content of the zero
time samples was checked against a standard of oxytocin
diluted in phosphate buffer in 12 experiments (including
one experiment with each inhibitor)•
The effects of various inhibitors were evaluated
against the percentage residual oxytocin in the control
tube. As previously established, under the present con¬
ditions of incubation, the latter reading bears a negative
linear relationship to the enzyme activity when plotted
on a semilogsrithmic scale. The percentage inhibition
was then calculated from the equation
Log a - Log b x 10Q
Log 100 - Log b
fthere a is he percentage residual oxytocin after incubation
in presence of a specific inhibitor, and b is percentage
residual oxytocin in a parallel control experiment with
the same plasma. A similar method for calculation was
employed toy Hooper (1959), who, however, used the same
placental oxytocinase prej^aratlon in all experiments, and




(1) Observations on the Biological Assay or Oxytocin on
the Isolated Hat Uterus
In the course of this study, the uteri from 116 rats
were employed# Of these, 34 proved to be unsuitable. The
main difficulties encountered were -
i Persistent and excessive spontaneous motility.
Spontaneous contractions were invariably noticed
when the uterine horn was initially suspended
in the bath, but usually settled down after a
period of half to one hour. Occasionally, how¬
ever, activity persisted, making the preparation
unreliable for the assay of oxytocin. In some
cases, excessive motility was overcome by
reducing the temperature of the organ bath by
1 - 2°C. It was noticed that uterine horns
stored overnight at 4°C rarely showed excessive
spontaneous activity,
ii Lack of sensitivity: Although diminished
sensitivity was commonly noticed within 2-3
hours in many preparations, a few uterine horns
did not respond to comparatively large closes of
oxytocin from the beginning of the experiment.
The sensitivity could be increased in some
instances by raising the temperature of the bath,
but the resultant responses commonly became of
the all or none variety. In the latter part of
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the work, preparations which did not respond
to 15 m.U or oxytocin at the beginning of the
experiment were discarded forthwith,
iii Lack of discrimination* Despite good sensitivity,
some preparations responded in all or none
fashion, and were thus useless for quantitative
work.
In suitable preparations, the sensitivity of the
horns to oxytocin varied widely. Most uteri reacted to
doses ranging from 1 to 12 ra.U. in the 2 ml. bath. The
sensitivity thus varied between 5-6 m.U./ml.
The precision of the assays can be estimated by the
value of )\ , (Gaddum, 1953). In the present work, 76
it-point assays were carried out. The value of ^ varied
between 0.03 and 0.11, the modal value being 0.0?» The
standard error of the individual assays ( ^ R) ranged
from 5-8 to 15.8.
The accuracy of the method was determined by
recovery experiments, in which the unknown (U) was a
dilute solution of oxytocin in phosphate buffer prepared
by a second observer. The results of 7 such experiments
are shown in Table 7» and indicate an average percentage
recovery of 102.5 with a mean error of £ 11.?$!.
(2) Oxytocin Recoveries in 2!cro Time Lamples
When xero time samples were assayed against a
standard of oxytocin, the percentage recovery varied





Estimated U/S % True U/O g # Recovery
1 0.08 116.2 125.0 93.0
2 0.08 101 .4 100.0 101 .4
3 0.10 97.8 83.3 117.4
4 0.05 100.0 108.0 92.6
5 0.07 112.4 130.0 86.5
6 0.05 76.$ 66.7 115.0





Recovery JSxperimente on "Unknown" Solutions of
Oxytocin
66
1000 m.U./ral. with an average of 92.6 (- 10.6)• There is
thus no clear evidence that the presence of deproteinised
plaama, placental extract or any of the inhibitors intro¬
duces an additional elaaent of error in the results by an
effect on either oxytocin or the assay preparation.
(3) desidual Oxytocin In the Control Incubations
Following 60 minutes incubation under the present
experimental conditions, the residual oxytocin varied
between 9 and 36?- in 16 experiments with plasma samples
from different subjects, and between 2.5 and 16? in 6
experiments with different placental extracts. The
enzyme activity in the two sources were thus approximately
comparable.
(6) Effects of Inhibitors
The results of the inhibition experiments with plasma
and placental oxytocinase are shown in Table 8. Of the
heavy metal ions, inhibition was marked with Sn44", Cu44
and Ag+4 for both placental and plasma ensymes. Parallel
results were obtained with Fe+ + and Sulphydryl inhibitors,
where no loss of activity could be detected. Metal-
chela ting agents however, produced 65«5 - 100?- inhibition
of plasma oxytocinase, but had no inhibitory effect on
the oxytocinase activity of the placental extracts.
COgOUJOIOHS
1 Incubation of oxytocin with plasma from pregnant
subjects (36-60 weeks gestation) leads to loss























EffectofInhibitorsnOxytoci aaeActivitiesinPr g ncylaanadPl ce t lExtr c s. AllInhibitorswereEmploy dinaConcent ationf10**^,xc ptB.D.T.A.( 0""2M)All PigureaaApproximated'thNe restWholeu ber.
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on isolated ratfs uterus. The kinetics of the
enzymatic reaction follow a first order curve.
Inactivation amounts to approximately 30 to $0^
of oxytocin in the Incubation in the first 10
minutes, and 75 to 9Qf in 60 minutes.
2 Oxytocin is also inactivated by incubation with
extracts of term placentae. The enzymatic activ-f
ity of 0.4 to 0.5 ml. of a 50% placental extract
is approximately equivalent to the activity in
one ml. of plasma near to term.
3 The plasma and placental enzymes are stable, and
show similar inhibition by heavy metal ions and
sulphyciryl inhibitors. The plasma factor howeveif
is inhibited by metal-chelating agents which do





A PAPER CKHO :4ATOORAPHIC STUDY OF Til is 1I5CHANISM OF ENZYMATI C
DEGRADATION OF OXYTOCIN AND VA30PR1MCIN BY PR G ANCY S -RA
Tuppy and, Nesvadbe (1957) employed paper chromato¬
graphy to study the enzymatic degradation of oxytocin by
pregnancy sera# They reported that, following enzymatic
inactivation of oxytocin and oxidation of the degradation
product, a substantial amount of cysteic acid could be
detected by paper chromatography# Tuppy and Nesvadba
(1957) thus concluded that pregnancy serum oxytocinase
inactivates oxytocin by splitting the peptide bond between
the cystine and tyrosine residues# The report, however,
lacks all details about the substrate employed, the con¬
dition© for Incubation, and the paper chromatographic
techniques used#
Nevertheless, paper chromatography was chosen for
the present study as it helps to separate and identify
compounds injugps amounts by a comparatively simple process
The exact mechanisms involved in this separation are not
fully understood, but as pointed out by smith (1$60) they
include:
i Continuous partition between the solvent flowing
along a filter paper and the water held in it
(filter paper contains approximately 155 of its
weight of water)#
ii Active adsorption of the compounds to the paper
which thus acts in a similar manner to alumina
columns#
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iii Ionic binding and exchange as filter paper has a
strong affinity for polar molecules which are
held by hydrogen bonding* and can also function
as an ion-exchange material due to its content of
hydroxy1 groups.
The Interaction of theae various factors results
in migration of compounds applied at the origin to
different characteristic distances. For convenience, the
final position of a substance on the chrornatogram is
specified by its "R^" which is the relative migration
rate obtained by dividing the distance to which the material
has moved from the original point of application by the
distance the solvent front has travelled from that point.!
The relative migration rate (Rf) for a specific compound
in a particular solvent is affected by many factors,
including th© size of the chromatography tank, the atmo-
spheric temperature, type of paper employed, the direction
I
of flow of solvent (ascending or descending), the length
of the solvent flow, a© well as the pW, and, th© inorganic
salt concentration in the caaterial applied at the origin.
The Rj, value for a compound is thus not an absolute index
(e.g. like th© melting point), but is quite reproducible
in cloy to day experiments in the same tank and usually
reasonably comparable in different laboratories.
Ordinarily, however, pure reference substances are devel¬
oped under the same conditions for comparison and identi¬
fication of unknown constituents in a mixture.
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The first observations on paper chromatography of
posterior pituitary peptides were made by Mueller et al
(1951)* who employed this technique to investigate the
effect of oxidation of purified natural oxytocin by
performic acid* The amount of material applied at the
origin for chromatography can be calculated as approx¬
imately 0.25 mg.» and the oxidation product was located
with Kinhydrin reagent. Paper chromatography has sub¬
sequently been employed to separate and identify the
various polypeptide hormones of the neurohypophysis by
many workerrs Including Benfey (1953); Schally et al (195$)
Acher et al (195$); Heller and Bederla (195$); Boissonnaa
and Huguenin (1960); Hope et al (1962) and Aroskar et al
(196^)* Table 9 summarises some of their relevant
methods and results when the polypeptides were developed
in a solvent of n-Butanol-acetic acid-water. As expected,
the results are fairly comparable but not Identical#
Preliminary Observations and Design of the Present
Experiment.
a Choice of the solvents
Review of the literature revealed that n-Butanol-
acetie acid mixture (Partridge, 191+8) was
the most widely employed solvent for character¬
isation of posterior pituitary polypeptides. The
available data could thus provide a basis for
comparison. This solvent was thus adopted for
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acids (L-Cyetelne, L-Cystine, L-Cysteic acid)
which form a basic residue in oxytocin and vaso¬
pressin molecules do not run in this solvent and
have values very near to zero (Smith, 19&G).
It was thus decided to use another solvent, Meth¬
anol-Pyridine (Smith, 1960) in parallel to enable
their identification,
b Choice of Technique for Chromatography
Both ascending and descending techniques have
been employed by different workers. However,
ascending chromatography techniques required a
long time for development, e.g. 16 - 18 hours in
Bu-A reported by Heller and JUederis (1956)*
cut down experimental time it was decided to
employ descending chromatography•
c Choice of Paper
Initial trials were done in both solvents on
batman No. 1 and Whatman No. 4 chromatography
paper# In Bu-A, it was found that a run of 20 cm.
required 5-6 hours for descending chromatography).
The same result was achieved within 2*? - 3 hours
on Whatman No. 4 paper with equally good separation.
Subsequently all chromatographic experiments in
Bu-A were carried out on »batman No. 4 paper.
In parallel experiments with Methanol-Pyridine
(Me-P) a 20 cm. solvent run on Whatman No. 1
paper required 2£ - 3 hours. Although Whatman No.
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paper gave a ran of similar length in only 1 -
hours, the resultant separation was less adequate,
Subsequently all chromatography work in Me-P was
carried out on Whatman Ho. 1 paper.
Choice of Location Agent
Table 9 shows the various staining procedures
employed to locate the pituitary polypeptides on
paper chromatograms, and their reported sensitivi
when the data were given in the publication. In
the initial experiments, oxytocin solution was
applied to a Whatman Ho. 1 strip as a compact
spot in amounts of 2 to 20 jugm (1 - 10 U-) and the
dry papers were then treated by one of the
following location agents:
1 Hlnhydrln Reagent
The paper was dipped in Hinhydrin solution
in acetone (0.2f> wt/v), hung to dry and then
heated for 5 minutes at 100°C. A faint pink
staining was obtained only with the high doses
(20 jam)* The relative insensitlvity of Ninhydriii
reagent to pituitary polypeptides has been
commented upon by Heller and Lederis (1938) who
remarked that Ninhydrin only reacts with terminal
amino groups. It is thus not the ideal reagent
for locating the pituitary cyclo-peptidee.
2 i-'olin*8 t'henol descent
In alkaline medium this reagent gives a
violet blue colour in presence of proteins and
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peptides containing the phenolic amino acids
tyrosine or tryptophan# A solution of synthetic
oxytocin gives this reaction. The same principle
was introduced by Arimura and Dlngman (1959) as
a sensitive method for detection of oxytocin and
vasopressin on paper chromatograms, using
specially treated glass fibre paper. They could
stain amounts of 0.5 ja&n of the peptides
(approximately 0.25 U-) • In our experience, 2 jagti
of oxytocin could easily be stained on Whatman
paper by the Arimura and Pingman method (1959)*
However, when chromatography was attempted in
Bu-A it was very difficult to locate the peptide
spot by Folin*s reagent spraying even with amounts
up to 8 yugms due to heavy bluish background
staining of the paper.
Chlorination Method
Sy&an and Smith (1952) reported that micrograms
of peptides (including cyclopeptides) can be
detected by chlorination followed by spraying
with starch-potassium iodine solution. Reindel
and Ifoppe (1954) improved this procedure in two
ways. First, before? exposure to chlorine, they
moistened the paper with a mixture of aqueous
ethanol and acetone, which prevents background
staining. Secondly, they treated the II-Chloro-
peptides with a mixture of potassium iodide and
7k
cither O-Tolidine or Benzidine in acetic acid
and thereby increased the sensitivity of the
method# Heller and Lederia (1956) introduced
this technique for paper chromatography of oxy¬
tocin, vasopressin and their analogues. In the
present study, this method proved very satlsfact-»
ory. Oxytocin (k ju®n) and vasopressin (2yugm)
can he confidently located "by this method on
paper chromatograms. Heller and Lederis reported,
an even higher sensitivity (3 jugrs for oxytocin
and 0.7jugm for vasopressin).
The reagents required for this reaction were;
AcetonesAbsolute Alcohol mixture 1t1 by volume.
Potassium Permanganate solution (3«2 gr^/
litre).
HC1 10f, (i dilution of conc. HC1).
O-Tolldine (reagent grade) in 2^ acetic acid
(saturated solution).
Potassium Iodide aqueous solution (16.6 gny'litre),
Acetic Acid 2$ in water (v/v) •
Location of the peptides involved the following
steps:
a The dry chromatography strip wm wetted in acetonei
aboolute alcohol mixture and immediately blotted between
two sheets of clean filter paper to remove the excess of
the reagent.
b The moist strip was then suspended in a plastic
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container measuring 22.5 x 22.5 x 9 en*. Twenty mis. of
potassium permanganate solution were poured into the
bottom of the container, followed by an equal volume of
HC1. The lid was replaced and the container rocked gently
for 5 minutes (by the stop watch) to ensure adequate
mixing of the permanganate and acid. This step was best
carried out in the fume cupboard to minimise the spread
of chlorine when the lid was removed. In addition to
being an irritant, the gaseous chlorine was likely to
interfere with the next step.
c At the end of 5 minutes, the chromatography atrip
was immediately transferred into a staining tray contain¬
ing equal volumes of O-Tolidine and potassium iodide
solutions, freshly mixed together. All parts of the
paper strip should be submerged at once for 2 minutes.
Peptides appeared as yellow spots quickly changing into
violet blue. The staining tray should be kept at some
distance from the source of chlorine, otherwise flakes
of blue stain form on the surface of the O-Tolidlne
potassium iodide mixture and smudge the chromatography
strip, giving rise to artefacts and making identification
of the true spots very difficult.
d The chromatography strip was washed in 2 changes of
2$ acetic acid, blotted between two sheets of filter paper
I
and hung up to dry at room temperature.
The colour faded out In daylight within a few hours,
and the spots v^ere thus outlined immediately after staining.
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In individual experiments, the density of the colour was
roughly proportional to the peptide load#
The use of a sensitive location agent in the present
study was essential for the following reasonst
1 To minimise the amounts of peptides employed as
we only had a very limited supply of the pure
highly concentrated oxytocin and vasopressin#
2 Although concentration of the peptides and their
cleavage products, by evaporation under reduced
pressure, before chromatography was technically
possible, this procedure is attended by a risk
of polymerisation in case of the posterior
pituitary peptides (Resaler, 1958)* It was thus
decided to avoid this step and work with more
dilute mixtures and a sensitive staining agent#
e Observations on the Deprotelnination of Pregnancy
Sera#
The high sensitivity of the chlorination method for
staining introduced ai source of error in our proposed
experiment# Pregnancy sera contain 5 - 6 gm^of proteins
which are stainable by the Reindel and Hoppe method#
Complete and thorough deproteinisation was thus mandatory
before the incubated peptides (or their degradation
products) couia be identified on the paper chromatograra#
Experiments were thus carried out to test the efficiency
of the various methods for tleproi* inisation of pregnancy
sera# A mixture of equal volumes of pregnancy sera and
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phosphate buffer (o#2 M, pH 8) was deproteinioed with the
following methods:
i Heat coagulation for 5 rainutes in a boiling
water bath#
il Acetone precipitation 1M by volume,
iii Precipitation with 1:1 volume of 10% and 20%
trichloracetic acid#
After shaking the mixtures were contrifugcd at
2000 r.p.m# for 10 minutes, and the clear supernatant was
tested by paper chromatography, employing the Heindel and
Roppe method for staining# £hen a load of 200 p.1 was
tested, subsequent chromatography revealed, in all instances
the presence of several (3 to 5) chlorination positive
spots (Fig# 12)# A control estimation of the deproteinlsed
mixtures by Folin*o reagent (Miller, 1958) also gave sub¬
stantial reading for these serum "blanks"• It thus
appeared that simple deproteinisation by any of the above
methods was not sufficient for our study# Following
incubation with oxytocin and vasopressin it would have
been almost impossible to identify with confidence the
formation of new compounds on the chroraatogram#
Although no attempt was made to identify these
chlorination and Folin positive compounds individually,
it was suspected that they might be free amino acids of
low molecular weight# Ke therefore tried the effect of
dialysis# Pregnancy sera were dlalysed In Visking
cellulose seamless tubing against distilled water for 3
; t- f u A/ -V/fi-
V
&M. ■ 4-
Figure 12 Paper Chromatogram Showing
Effect of Preliminary Dialysis of Sera*
Load 200 ;aL* of Trichloracetic Acid Be-
Proteinlsed Serum* Descending Chrom¬
atography in Bu-A*
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hours at k°0 (in the refrigerator). The sera were then
diluted with phosphate buffer (1:1) and deproteiniaed
with ZO/: trichloracetic acid, equal and half volumes.
Following centrifugation, the clear supernatant was
chromatographed employing a load of 200 jul. Control runs
of the same serum blanks without dialysis were also done.
After development in Bu-A the papers were dried and
stained by the Reindel and Hoppe method. With few
exceptions, the dialysed serum blanks showed no stainable
chlorination positive compounds, in contrast to the un-
dialysed controls (Fig. 12). Dialysis was thus instituted
as a basic step in subsequent experiments. Prior to
incubation with oxytocin or vasopressin all sera were
dialysed. A serum "blank" was prepared (50?' in phosphate
buffer) deproteinised toy half volume of trichloracetic
acid, and tested by paper chromatography. Only sera which
produced a clean chromatogram devoid of interfering
compounds were accepted for subsequent incubation.
f JSffect of Dialysis on Oxytoclnasc Actlvity•
According to Werle et al (19^1) and Page (19M>)
the oxytocinase activity of pregnancy sera (assayed bio¬
logically) is not affected by dialysis against water.
Table 10 summarises the results on 10 pregnancy sera.
The oxytocinase activity was estimated by the chemical
method described by Tuppy and Neavadba (1957) before and
after dialysis for 3 hours against distilled y/ater at h°C.








1 9.2 8.9 96.7
2 7.5 7.3 96.0
3 6.2 5.9 95.0
4 5.6 5.4 96.4
5 5.7 5.6 98.3
6 10.9 10.5 96.3
7 6.9 6.6 95.7
8 8.3 7.S 95.2
9 4.7 4.5 95.8





Kffect of Dialysis on Serum Cystine Aminopeptldase
Activity "Oxytoclnase"
The Results ape Expressed as mg. A naphthylamine/
100 ml. Serun/Hour. (See page 100)
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Instances which could be accounted for by the inevitable
alight volume increase and dilution of sera luring dialysis,
g Values of Oxytocin and Vasopressin.
The chromatographic behaviour of oxytocin and vaso¬
pressin^) was studied In two solvents.
i n-Butanol^jater-A.eetic Acid 1+0:1GS5Q (on Whatman
Ho. k paper)
ii i%thanol-Waier-Pyridine 160jLGs8 (on Whatman
Ho. 1 paper)
The peptides employed were synthetic Oxytocin,
synthetic Lysine-vasopressin, synthetic Arginine-vaso-
presaln and natural Lysine-vasopressin (Pitresain).
Amounts of 2 - 4 units of the peptides (L - 8yugms
approx.) were applied at the origin and the chromatograms
were developed to a length of 20 eras# by the descending
technique in 2& - 3 hours. The peptides were located by
the Reindel and Hoppe ehlorination method.
The results are shown in Pigs. 13 and 1L and
Tables 11 and 12. Single spots were obtained with all
pure synthetic compounds in both solvent media. Commercidl
Pitressin solutions gave a single apot in Bu-A which
corresponded well with that of synthetic Lysine-vasopressin.
In Mo—P, however, it showed as 2 - 3 spots, one of which
had the same as the pure? synthetic vasopressins. The
Pitresain solution was thus regarded as unsuitable for
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i ■ .'viSt Mt- e
ip'Mve 1U Chromatography of i-ost
erior Pituitary fioxraones in HeP«
Dome Loado as Figure 13*
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Sffi 11
Peptide""""""" Ho* of " ' R™""Average Range
Kxps
Oxytocin 14 0.41 0.37-0*43
Lye.vasopressin 5 0.12 0*10-0.15
Arg.vasopresein 2 0*23 0*22-0*24
Values of Synthetic Oxytocin and Vasopressins in a





Oxytocin 8 0*82 0.78-0.83
Lye• vasopressin 5 0.62 0.77-0.67
Arg. vasopressin 2 0.81 0.60-0.82
Values of Synthetic Oxytocin and Vasopressins in a
Solvent of Methsnol-f^O-Pyrldine (160:40*8)
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The peptides have different R., values in Bu-A, but
migrate to the same distance in Me-P. The results of
chromatography in Bu-A are in good agreement with those
obtained by other workers, as shown in Table 10.
h Sffect of Oxidation on Oxytocin and lysine-
Vasopreasin
Controlled oxidation of oxytocin and vasopressin
by perforate acid results in disrupt ion of the disulphide
bridge between the two half-eyotine residues (in positions
1 and 6) with formation of an open chain compound which
gives a single spot on paper chromatography. Ho free
cysteic acid is liberated from the molecule (Mueller et
al, 1951).
A simpler method for oxidation was tried by employing
30? Hydrogen Peroxide solution as described by Smith (1960).
Fresh peroxide solution (0.1 ml.) was added to O.i* ml.
of synthetic oxytocin (200 U/ml., pH 3*5)• All solutions
were precooled to k°C, allowed to stand after mixing in
an ice-water bath for 10 minutes, and then immediately
applied to Whatman filter paper strips for chromatography.
L-eysteic acid (8 jugm) was also run on the same strips
as a marker. The results are shown in Figs. 15 and 16.
A single oxidation product was obtained in all cases. The
oxidation products of both oxytocin and lysine vasopressin
had lower Rf values in both Bu-A and Me-P than the parent
molecules. No free L-cysteic acid was identified in the
oxidation mixtures.
fflggre 15 Effect of H90o Oxidation of
Synthetic Oxytocin (Ox«, Ox. Ko0„), and
Synthetic 8-Lys ine-Vasop re s sin** (?;• V» P» ,
L.V.F. H20?)» Loads h tJ• (appi*QX»)«Deocending^chmnatography in Bu-A*




Figure 16 ssffeet of H^O,, Oxidation of
Synthetic Oxytocin (Cx», Ox. H^Og) and
Synthetic e-Lysine-Vasopreesin (I.V.P»,
L.V.P# KgOg), Loads h V* (appro*,)
L-Cysteic Acid (Cys) Hun as a Marker
in a Load of 8 /igm. Descending chro¬
matography in Me-P«
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i The Final Experimental Design#
Having established the suitable conditions for
chromatography of oxytocin, vasopressin and their oxidatiob
products, and for satisfactory deproteinisation of preg¬
nancy sera, the enzymatic effects of pregnancy sera on
either hormone were studied according to the following
design:
i Selection of sera of high oxytocinase activity,
ii Incubation with oxytocin or lysine vasopressin
at pH 7*j8.
iii Deproteinisation of the incubation mixture,
lv Oxidation of part of the protein free super¬
natant.
v Separation and identification of the enzymatic
degradation product(s) and their oxidation
yield by paper chromatography.
,Material and Methods
1 Hormonal oubstrates
The synthetic chemically pure polypeptide hormones
employed in this study were obtained in the following
forms.
i Synthetic Oxytocin: concentrated solutions were
obtained from Parke Davis and Co. (198.95 H/ml.,
Batch No. U5985# 10 ml. vial) and Sandos Ltd.,
(L50 U/ial., one ml. ampoules). The solvent was
a sodium acetate-acetic acid buffer pH 3.5
(approx.) in both preparations.
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ii Synthetic Lysine Vasopressin: concentrated solution
containing 120 0/ml. watery solution acidified by
drops of dil. HC1 to pH 3»5» This preparation
was obtained from Professor J• Rudinger, Prague,
in one ml. ampoules.
Buffer
Sodium phosphate buffer pH 8, ionic strength Q.2 M.
The relatively high ionic strength was required to neutralise
the acidit- of the hormonal substrate solutions.
Chromatographic Solvents
n-Butanol-7ater-Acetic acid 1+G:1G:5Q (Partridge,
1948). She mixture was thoroughly shaken and allowed to
stand overnight• The upper solvent layer wa3 used for
jjh roraa tog raphy •
Methanol-Water-Pyridine I60xl+0t8 (Smith, 19^0). Th©
mixture formed a monophasic solvent. Solvent stock
solutions were prepared every 3*4 weeks and stored in
She refrigerator. The solvent mixtures in the chromatog¬
raphy trough were changed weekly.
Other Chemicals
Hydrogen Peroxide 30f. (wt/v)
Trichloracetic Acid 20} In water
Chemicals for the "eindel and Hoppe location method
(page 74)
Chemicals for chemical estimation of oxytocinase
(page 97)
Chromatography Apparatus
Two Chandon glass chromatography tanks were employed
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throughout# The larger tank measured 50 x 50x 20 cm#
and was used for descending chromatography in Me-P. A
smaller tank, 30 x 5k x 18 cm# was employed with Bu-A#
Initially and with every change of solvent, the lid was
replaced and the tank was left to saturate and equilib¬
rate overnight#
Chromatography strips were cut out frora larger
sheets of Whatman No# 1 and No# k filter paper for chro¬
matography# Strips employed were 3k cm. long and of
suitable width so as to allow application of the various
solutions for chromatography at 3 cm# distances on the
origin line, leaving a free margin of 2 cm# at the sides.
The papers were marked at 20 cm. from the origin line to
indicate the end of the run#
Micropipet tea (10 jal) were used to apply the material
for chromatography at the point of origin so a® to ensure
a compact small spot# A current of warm air from a hair
drier was employed to help dry the paper between the
applications#
Experimental Procedure
1 Collection of Blood Samples
Venous blood samples (15 ml.) were obtained from
patients 36 or more weeks pregnant# Samples were obtained
whenever possible from patients with twin pregnancy to
ensure a high oxytocinase activity of sera (Page et al,
1961)•
2 Separation and THalysis of Sera
After clotting of blood, sera were separated by
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spinning at 2000 r.p.m. for 10 minutes. The supernatant
serum was decanted. A suitable volume (k - 6 ml.) was
poured into a prewetted Visking cellulose dialysis tubing
I^iaiysie was carried out in a 5 1 container against
distilled water for 3 hours at 4°C.
3 Selection of Gera for Incubation
Subsequent incubations with hormonal substrates was
limited to serum samples which fulfilled the following
two conditions:
i A high oxytocinase activity as tested by Tuppy
and Nesvadba*e chemical method (1957)*
ii A chromatographically "clean" blank as tested in
the following way: 1 ml. of dialysis serum was
mixed with 1 ml. phosohate buffer and 1 ml. tri¬
chloracetic acid. Following mixing and centrif-
ugation, the supernatant was decanted and applied
to Whatman No. h paper strips in loads of 200 jul.
The strips were developed in Bu-A and stained by
chlorination. Sera which gave no retainable
ingredients following this treatment were
considered reliable for subsequent incubation.
k Incubation with Oxytocin and Vasopressin
Incubations were carried out under the following
conditions:
1.5 ml. dialysed sen® + 0.?5 ml. phosphate buffer +
0.75 ml. of either oxytocin (200 U/ml.) or lysine vaso¬
pressin (120 U/ml.). A drop of chloroform was added as
preservative and the reaction of the mixture was tested
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by B.D.H. pH paper. In all cases It was found to lie
between 7 - S.
The test mixture (T) was incubated at a temperature
of 37°C (* 0.5) for 2k hours.
A control (C) was prepared in all experiments with
the same composition, and v/as stored for a tjimilar length
of time at k°C»
%proteinlsation
At the end of 2k hours, the test and control mixtures
we deproteinised by | volume of 2£$ trichloracetic acid.
The tubes were shaken and then centrifuged (2000 r.p.ra.
for 10 mine). The clear supernatant was decanted into a
clean test tube and stored at i+°C.
Oxidation
This was carried out immediately before chromatography.
A volume of 0.8 ml. of the deproteinised Incubation
mixture (T) was treated by 0.2 ml. of hydrogen peroxide
in a micro-test tube. The tube was shaken and then
stood in the ice-water bath for 10 minutes. The mixture
(THgOg) was then applied to the paper strips for chrom¬
atography.
7 Chroma tograohy
The following solutions were run together on the
same strip:
Control (C), Incubation Mixture (T), oxidised
ncubation Mixture (THg0o), L-Cysteic acid "Cys" (8 jugsn)
and THgOg + Cys. on the same origin point.
The loads employed were 200 jal* in the oxytocin
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incubations and 300 jil. in the vasopressin experiments.
Two strips were employed for each experiment, one
for development in Bu-A (Whatman No. It) and the other
for development in Me-P (Whatman No. 1).
A twenty cm. run in either solvent was obtained
within 2^-3 hours. The papers were then hung to dry
and stained toy the Reindel and Roppe method.
,
penults
1 direct of the Experimental Procedure on the Ohrom-
atopcranhic behaviour of Oxytocin and Vasopressin
Table 13 compares the values of oxytocin and
lysine vasopressin applied directly to the chromatography
paper as pure compounds with the values obtained from the
control mixtures (c). No significant differences are
seen when Me-P is used for developing the ohrometogram*
In Bu-A, oxytocin also has the same in contrast to
lysine vasopressin which had a significantly smaller
value in the controls as compared to the pure substrate.
The effect may be due to the high acidity of the deprotein-
ised control mixtures (^H <^1) resulting from the use of
trichloracetic acid for deproteinisation. The effect is
shown in Pig. 17 when lysine vasopressin (h V) la run as
a pure substrate and in a control mixture in Bu-A.
2 Effect of Incubation with Pregnancy Sera
Following incubation with pregnancy sera, chromat-
ography of the deproteinised test mixture (T) revealed in
i
all instances substantial degradation of oxytocin and
'
lysine vasopressin as evidenced by fading of their
r.ignra 17 Descending Chromatography
of Lysine-Vaaopresain as rure Comp¬
ound (A.V.P. , 3 U»), and. in a Control
fixture (C«, 300 yuL»). Solvent: Mc-P.
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TAP**' 13
Peptide Uf in Bu-A Rf in Me-P
Oxytocin 0.1*1 0.02
Oxytocin in
Control Mix. 0.1*3 0.83
Lysine-Vasopreasin 0.12 0.82
Lysine-Vasopreasin
in Control Mix, 0.09 0.79
Values of Oxytocin and Lysine-Vasopressin Sun as Pure
Compounds and in the Deproteinlsed "Control"
Mixtures
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chromatographlc representative spot (as compared with the
control C). In most cases, however, it was still poasiblei
to identify traces of the hormones in the chromatogram.
A new product was shown on all chromatog rams
which had a higher value than the parent hormone in
Bu-A, and smaller value in Me-P (Figs. 18 and 19). Tablen
a,b a,b
1h and 15 sum arise the R*, values of the main cleavage
products following Incubation of oxytocin and vasopressin
with pregnancy sera.
With oxytocin incubations a faint second new spot
was obtained occasionally when the test mixture war run
in Bu-A with an value very close to zero.
3 'Affect of Oxidation on the Hnzymatlc Cleavage
Products of Oxytocin and Vasopressin
On chromatography of the oxidised test mixture
(TH^O ,) of oxytocin in Bu-A solvent, the enzymatic cleavat,
product (Rf:0.8l) disappeared and a ©ingle spot was seen
with an very close to zero, (0.032). The results are
shown in Fig. 1& and Table 1h* It must be noted that in
a
this solvent L-eysteic acid also had a very low Rf (0*03)
ae shown in the same figure. With Me-P, however, chro¬
matography of the oxidised test mixture of oxytocin
revealed two components with average 8^ value of 0. 5 and
0.61. Fig. l8^also shows that L-cyeteic acid had the same
value as the slower moving of the two components.
Furthermore, when the oxidation mixture and L-cyateie
acid were applied to the same point of origin, the two
oxidation components were again seen with the proximal
e
T " T'+ *nsv L-Cr^
Figure 1 £a Paper Chromatography of 3yn
the tic oxytocin, and. its Products on
Onzymatic I-egradation and Further Oxi¬
dation; Load of 200 /iL. of Control "C"
Test and Oxidised Test "THgOg". L-
Cysteic Acid (8 /ngn.) Run as a Marker:
alone "Cys" and with the Oxidised Test
fixture (TH„0o + Cys.)« Chroniatograra
t- 6
developed in Bu-A«
C T* THtOX l-M- T^j-cyy
« « * « • «
■0./
wwr J a/£ p
—* 1
Figure 18b Paper Chromatography of Syn¬
thetic Oxytocin, and its Products on
Ensymatic Degradation and Further Oxi¬
dation; Loads of 200 pL, of Control "CH,
Test "T"t anu Oxidised Test "TH^Oo"*
Cysteic Acid (8/jigrn.) Run as a MarKer:
alone "Cys" and with the Oxidised Test








Figure 19a Paper Chi^omatography of 8-
Lysine-Yasopregain and its Products on
Pnoyraatic Degradation and further Oxi¬
dation# Loads of 300 jiiL* of Control
nC§ Tost Mixture "T«, and Oxidised
Test Mixture WTH2©2% D-Cysteic Acid
(8 fign*) Sun as 8 Markers alone "Cys"
and with the Oxidised Test Mixture
(TH20? + Cys) • Chromatogreun Bevels
open in Bu-A#
Figure 19b Paper Chromatography of 8-
Cysine-VaaopreesIn and its Products on
Enzymatic Degradation and further Oxi¬
dation* Loads of 300 luL. of Control
"C", Test fixture / and Oxidised
Teat Mixture "Tf1„0 "• L-Gysteio Acid
(8 jugnu) Run as 'a ' Marker: alone "Cys"
and s'^ith the Oxidised Test Mixture
(TH202 ♦ Cys»). Chroniatogram Devel¬
oped "in Me-P#
yAftL5fa
Material ControlHC" Test OxidisedTe t "THgOg" L-Cysteica. "Cys"




0.43 (0.40-0.45) 0.84 (0.75-0.89) 0.032 (0.02-0.05) 0.03 (0.03-0.05)
0.83(0.80-0.88) 0.44 (0.39-0.48) 0.5061 (0.43-0.54)58 65 0.50 (0.43-0.54)
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component showing intense etaining by the superimposed
L-cysteic acid spot.
In similar experiments with lysine vasopressin, a
closely parallel pattern was observed. On oxidisation
of th© teat mixture the enzymatic cleavage product which
had an average value of 0.22 in Bu-A was replaced by
one spot with a low as seen in Fig. I9aand Table 15.
In Me-P solvent, two oxidation components could be
recognised, the slower one with the same as L-cysieic
acid. In this latter solvent medium the chromatographic
behaviour of oxytocin, lysine vasopressin and their
cleavage and oxidation products was nearly identical.
Cpnclusiona
The key reaction in these experiments is the oxidatioto
of the polypeptide hormones which is known to disrupt the
pentapeptide ring by attacking the disulphide bond between
the two half cystine residues (In positions 1 and 6).
The result is a single open chain polypeptide with 9 amino
acid components including cysteic acid residues in positions
1 and 6. This compound had a different to that of the
parent intact hormone as shown in our preliminary exper¬
iments. however, oxidation of oxytocin or vasopressin
does not lead to the liberation of cysteic acid.
By subjecting oxytocin and vasopressin to enzymatic
cleavage by pregnancy sera, the present experiments
revealed the formation of one main single compound. On
subsequent oxidation it has been shown that free oysteic
acid is split off the enzymatic cleavage products of both
9k
oxytocin and lysine vasopressin. As this does not happen
with the intact eyclopeptide hormones, it can be concluded
that ensyraatic degradation by pregnancy sera must have
resulted in cleavage of the peptide bond between terminal
half cystine (position 1) and the adjoining tyrosine
(position 2) residue#. The findings are Interpreted in
Pig. 20. The ensymatlc cleavage of oxytocin and vaso¬
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•S lmvo .20 Interpretation of the Chromatographic ladings,
Showing the Site of Cleavage of the Oxytocin and S-bysine
Vasopressin Joleculee by the Pregnancy Serum Snasyiae, and the





GK^ICAL MSrHODS ."'OH r'GTI'-- :v'f ION Or' PRfiQliANCY C::^UM QIYTOCI^^SS
Puppy and Nesvadba (1957) introduced the synthetic
compound L-Cystine-di- f> -naphthylaraid• aa a suitable
substrate for the chemical estimation of pregnancy serum
oxytocinaae. In this compound (Fig. 21) amino-terminal
half-cyetine real due a are linked to ^-naj.-h thylamine by
peptide bonds, a configuration similar to the N-termlnal
amino acid sequence of oxytocin, where the enzymatic
splitting of the hormone occurs. When incubated with
pregnancy sera, the synthetic substrate was split with the
liberation of ^-naphthylamine• The free y^-naphthylamine
was estimated colorimetrically by a modified Bratton-
Marshall reaction (Bratton and Marshall, 1939). Colour
development toy this method involved dlazotisation followed
by coupling with H~(1 Naphthyl) ethylene-dlamine-dihydro-
chloride. The intensity of the violet blue azo dye thus
formed was a xunction of the concentration of y^-naphthy¬
lamine over a wide range of spectrophotometry readings.
The amount of ^-naphthylnrnine released by enzymatic
splitting could therefore be detemined by comparison
to a standard solution of ^-naphthylamine. The details
of the method for colour development were essentially
similar to the procedure originally described by Green
et al (1955). The chemical reactions involved are illus¬
trated in Fig. 22.
Tuppy and Kesvadba (1957) also investigated the
kinetics of the enzymatic splitting of L-Cyetine-di- fe-
naphthylamide by pregnaney sera, and characterised the
aptiraal conditions for the enzyme assay.
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Figure 21 Chemical Formulae of Synthetic Compounds Used
for Pregnancy Serum Oxytoclnase Estimation# A# L-Cys-
tine-di-» ^-naphthylanide; B. s-Benzyl-cysteinyl- & -
naphthylamide# Sites of enzymatic cleavage indicated
by arrows.
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Under these conditions, the kinetics of the reaction
followed a zero order form, and the activity was expressed
by the number of milligrams of ft -naphthylamine liberated
by 100 ml. serum per hour. The chemical method was
reported to be more simple, accurate and precise than the
biological methods for oxytocinaae assay.
In 196h» Xuppy and Wlntersberger introduced the
compound S-Benzyl-Gysteine- -haphthylamide (Fig* 2f)
as an alternate synthetic substrate for oxytocinase
estimation. Following incubation with pregnancy sera,
-naphthylamine was released and was measured fluor-
imetrically (Xuppy, 1965)* This substrate is more soluble
in the incubation mixture than the previous one, and the
method was reported to toe more sensitive and of better
specificity.
This part of the work was undertaken to investigate
the following problems:
1 To examine the kinetics of the enzymatic splitting
of L-Cystine-di- -naphthylamide by sera of
women in late pregnancy.
2 To investigate the validity of the chemical
methods for oxytocinase estimation by:
I Studying the splitting of the synthetic
substrate L-Cyetine-di- ft -naphthylamide by
sera of pregnant animals and non-pregnant
females, in which oxytocinase has been
reported absent (Page, 19h&; lerle et al,
1950).
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II Examination of the effect of inhibitors on
the enzymatic splitting of the same substrate
by pregnancy sera and comparing the results
to the data reported in Chapter IT#
III Examination of the distribution of the enzym¬
atic activity towards the synthetic substrate
in the various protein fractions of pregnancy
sera obtained by ammonium sulphate precipitati
and paper electrophoresis, and comparing the
results with the published data on oxytocin-
ase (Oeram and Werle, 1956)•
3 To compare the two available synthetic substrates
for oxytoeinase estimation.
Material and Methods
Blood samples were collected from animals and human
volunteer® as described on page 46, liera were separated
by spinning and assayed for enzymatic activity within
46 hours of collection,
{1} Chemical estimation of Enzymatic Activity on h-cystine
on
A-naphthylamlcie substrate
The method described by Tuppy and Kesvadba (1957)
was employed with minor modifications. The following is
an account of the procedure -
ftgagentfl
Substrate Solution: L-cyatine-di- ft -naphthylamide,
135 «ig» was dissolved in 50 ml, of 0,012 N !IC1, with
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moderate wanning. The clear solution was diluted to 100 ntl.
with distilled water and stored in the refrigerator. The
substrate was obtained from Sanabo Company, Anton Scharff
Gaeae 7» Vienna.
Buffer
Veronal buffer pH 7.9, ionic strength 0.046 M (page 45).
standard Solution
-naph thylamine (S« Kodak Co.) 40 ang. was dissolved
in 900 ml. 0.012 H HC1 with warming and stirring, and
diluted to one litre with distilled water. The solution
was stored in the dark.
Other Reagents
Trichloracetic acid, 10 per cent (w/v), a mixture of
HC1 (0.36 N) and acetone (reagent grade) in the ratio
2H; sodium nitrite, 0.1 per cent aqueous; IT-1-naphthy1-
ethylenedlainine-dihydro-ehloride (K. Kodak Co.) 0.1 per
cent aqueous.
Fresh solutions of the standard as well as the reagents
for colour development were prepared every 2 to 3 weeks.
Serum, 0.6 ml. was diluted with 0.9 ml. water and
3.0 mi. veronal buffer; 0.79 ml. of the diluted serum
was pipetted into each of 3 micro test tubes. The first
of the three tubes served as the zero time control. Into
it was pipetted 0.29 ml. of substrate solution followed
lm ediately by 1.0 ml. of 10 per cent trichloracetic acid.
The remaining tubes (duplicates) were placed in a water
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bath at 37°C, and 0.25 ml. substrate solution was added
to each* After k hours at 37°C, the reaction was stopped
by the addition of 1 ml* of 10 per cent trichloracetic
acid* After shaking, the tubes were centrifuged, and
1*0 ml* of the clear supernatant solution was pipetted int^
a 20 x 125 mix. test tube. (If time did not permit devel¬
opment of colour on the same day as the enzyme reaction,
these tubes were stoppered and stored in the refrigerator
overnight)*
A reagent blank and standards were set up as follows?
1*5 ml. of water was mixed with 3«0 ml. bufter, and 0.75 m-.
of the resulting solution was pipetted into each of three
20 x 125 mm. test tubes. To the reagent blank was added
0.25 ml. of water, and to the standard, 0.25 ml. of the
standard -naphthy1amine solution.
Colour Development
This was carried out in a semi-darkened room. To
sach tube containing 1 ml. of supernatant (or standard)
far added 9 ml. of the IfCl-acetone mixture• The following
additions were made at 3 minute intervals (using a stop¬
watch) , and the tubes were mixed by shaking after each
additions 1 ml. sodium nitrite, then 1 ml. ammonium
sulfamate, and finally 1 ml. N-1-naphthylehylene-diamine-
dihydro-chloride. The tubes were stoppered and set in the
Incubator in the dark at 37°C for 4 hours. The maximal
solour was reached after 3-4 hours and remained constant
;.'or several hours. After cooling to room temperature, the




The enzymatic activity of the unknown serum was
determined by the following equations
Q.D. unknown - O.I), control „ c
0.1), standard - G.D. of blank
The product is the number of milligrams of ft -naphthylomine
liberated per 100 ml, serum per hour.
j(2) Inhibitor Experiments
The effect of inhibition on the enzymatic splitting
of L-Cystine-di- p -naphthylamide was investigated by
incubation with sera from women % - kO weeks pregnant.
The enzymatic activity of the serum was determined as
previously. In addition, 0,6 ml. of the serum was pre-
incubated with the inhibitor solution (0.9 ml.) for 15
minutes at 37°C, The same inhibitors described in Chapter
II were employed in a concentration of 5/3 * 1Q~"^M. The
final concentration of the inhibitors in the mixture was
thus 10"*^M , except in the case of E, D.T.A., where a final
concentration of 10""2M was aimed at. Veronal buffer (3*0 ml.)
was then added and the enzymatic activity was determined
as before.





there a is the enzymatic activity of a serum, and b is the
residual enzymatic activity of the same serum in presence
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of a specific inhibitor.
(3) Paper Electrophoresis of Pregnancy Sera
The separation of the serum proteins was carried out
under the following conditions!
A volume of 0.1 ml. of late pregnancy serum was app¬
lied in a linear fashion to each of two cellulose acetate
paper strips (Oxold). Sleetrophoresis was carried out in
an Eel X 118 electrophoresis apparatus in veronal buffer,
pH 7*9# ionic strength 0.05 M* Through each strip a
current of 0.3 m. amp. per cm. was run for approximately
17 hours to obtain a separation of 12 - 13 cms.
One of the strips was then dried in a hot air oven
(ten minutes at 80°G) and then stained for the various
protein bands with llssamlne green (I.e.X. product 8.P. I50t
0.3;* in 15f acetic acid in tap water) as described by
Gorringe, 1957* This strip was kept as a marker.
The other paper was cut up into 1 cm. strips while
still wet. The strips were then carefully transferred to
small test tubes containing 1.0 ml. of a mixture of
veronal buffer (pH 7*S» ionic strength 0.05) and distill et.
water (2:1). The strips were completely submerged and
allowed to stand for 2k hours in the refrigerator.
To each of the eluateo 0.25 ml. of substrate solution
was then added, and the mixtures incubated for 2k hours
at 37°C. The reaction was finally stopped by adding 0.75
of 10 per cent trichloracetic acid. The tubes were then
content
centrifuged and the p-naphthylomine^of 1.0 ml. of the
supernatant estimated. The recoveries in the various
ml.
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fractions were calculated in terms of ragnu fl> -naphthylamine
per 100 ml. serum per hour, and compared with the total
ensyme activity of the unfractlonated serum.
(h) Am .onium . uluhatc Fractionation of Pregnancy Oera
This was carried out by adding 2 ml. of a solution
of saturated ammonium sulphate in water to an equal volume
of late pregnancy serum of known cystine aminopeptldase
activity. After adequate mixing, the tube was centrifuged
at 2000 r.p.m. for 10 minutes. The clear supernatant was
decanted into a separate tube and dialysed against distilled
water for 3 hours. The protein deposit was washed twice
in two changes of 10 ml. distilled water, and finally
taken up in 0.9$ HcCl solution. The final volumes of both
the supernatant and deposit solutions were adjusted to a
volume of h.O ml. by 0.9/ ftaCl solution. The enayaatic
activity of both solutions was estimated and compared to
the activity of the unfractdonated serum after correction
for the dilution.
(5) Ohcmlcal ^tlaatlon of Enzymatic Activity on
S-Bengyl-Cybteine- -Naphth.vlamlde Substrate
The method described by Tuppy (19^5) was employed
with minor modifications.
Reagents
uiistrate Solution: B-Benzyl-Cysteine- TTaptiilljli»H
Ide, 168 mg., was dissolved in 50 ml. of 1:1 mixture of
5Q> mcthylceilueolv (2 methoxy-ethanol), and 0.01 N HC1
(v/v). This substrate was obtained from Professor K. Tuppy.
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Tris-HCl buffer 0.1 M, pH 7*9 (page h5)
Standard Solution of ^-naphthylamine containing
2 ugiV'2.9 ral. G.01 M NaGH. This was freshly prepared
every week by dilution (1s200) of a stock solution con¬
taining 13^.6 mg. ft-naphthy lamine per litre 0.01 K NaOI!•
Other Reagents
Jethylcellusolv 90^ in water (v/v)
NaOH 0.01 N
Method
Estimations were carried out in small tubes 10 x 75 ntn.
Duplicate tubes were used for the test together with a
zero time control, a blank and a standard.
The incubation mixture consisted of the following?
Buffer 50 pi.
Serum 10 pi.
Distilled water 10 pi.
Methylcelluoolv 20 pi.
The five tubes were then stood in a water bath at
37°C for ten minutes. The first tube was used as a zero
time control, and into it was pipetted 10 pi. of substrate
solution followed immediately by 2.9 ml. of NaOH. The
next two tubes (duplicates) were mixed with substrate
solution (10 701.) and incubated for 10 minutes in the
water bath at 37DC. The enzymatic reaction was then
stopped by adding 2.9 ml. of NaOH solution.
The remaining two tubes served as a standard and
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blank. The standard was prepared by adding 2.9 ml* of
-naphthylamine solution. The blank was prepa red by
adding 2.9 ml. of EfaOH.
The j3 -naphthylamine content of the reaction mixture
was then determined fluorimetrieally• The maximum activ¬
ation of this compound is at 335 nya. Using a Locarte
single sided fluorimeter MR 4 with a mercury arc lamp,
LP 1 filter on the primary side (range of transmittance
254-400 rap) and a colourless gelatine film on the secondary
side, a standard reference curve was prepared for ^-naph¬
thylamine in the range 0.1 - 2 jagrrvO ml. 0.01 N NaOH as
seen in Fig. 23.
The blank was set to zero and the standard to a
reading of 100. The percentage fluorescence of the un¬
known incubation mixture was read. After subtracting the
reading for the zero time control, the ^-naphthylamine
content was determined by referring to the standard curve*
The enzymatic activity was calculated as the number
of rags. -naphthylamine released by 100 ml. serum per
hour from the formulas
ft -naphthylarnine content of incubation mixture (in p.gm)
x 6 x 100Q
100
?r,sbit3
1 Kinetics of inzymatlc Splitting of L-Cystlne-dl* -
naohthvlamide by Sera of women in hate Pregnancy
The standard reference curve for ^-na.-hthylamine is
shown in Fig. 24* The relationship between the colour
1i
jjgm. ^-NAPHTHYLAMINE/3ml. OOIN NaOH
Figure 23 Reference Curve for Fluorimetrie
estimation of ^-naphthylamine• High Stand¬
ard Contains 2 ;agm. $-naphlbyiamine/3 ml*
0*01 15 NaOH. Excitation at 33S" <m/*-
Percentage Fluorescence Read at 410 mp*
Figure 2U Reference Curve for £pect ropho tomet rlc
Sstimatoh of /& -naphthyla^lne. The Optical Density
(0»D«) is Plotted Against the Concentration of fi-
naphthylaraine in jigns •
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density (expressed as optical density: O.D.) and the
naphthylam1ne concentration le linear over a wide range
and up to a reading of O.D. 0.6. The final concentration
'
of ^-naphthy1amine in the standards run In routine
assays was 10 ugm. which gave an average O.D. of 0.26
(- 0.003).
The time course relationship of the enzymatic reaction
under the standard conditions for incubation described on
page 98 is shown In rig. 25» where the /?-naphthylamine
release by specimens of serum from two subjects in late
pregnancy were estimated at hourly intervals. A linear
relationship is seen throughout the first four hours.
i?ig. 2.6 shows the relationship between the serum
concentration in the incubation mixture and the enzyme
activity expressed as the O.D. of the ^-naphthyiamine
released after four hours incubation. A linear relation¬
ship existed v?ith serum concentration between 0.0 and 0.2
ml. serum per ml. of the incubation mixture. At higher
| serum concentrations, the ^-naphthylamine release was
relatively less. In the standard method a concentration
of 0.1 ml. seruni/ml. of the incubation mixture was
regularly employed.
The effects of changes in pH are recorded in Fig. 27
Instead of veronsl-HCl, a universal buffer (Teorell and
dtenhagen*a citrate-phogphate-borate buffer, 1938) was
employed to allow investigation of enzyme activity in a
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Figure 25 Progress Curves of the Enzymatic
Splitting of S-Cyotine-dl-/0-naphthyXaraide
by Two Different .ate Pregnancy Sera* Enz¬
yme Activity Expressed as Optical Density
(Q»D,) of ^-naphthylaraine Released#
O.D.of p^Naphthylamine
Released.
Figure 26 Effect of Changes in the Serum Concentration
in the Incubation Mixture on the Enzymatic Splitting of
h-Cystlne-c!i- /2-naphthylamide (Expressed as Optical Density
"OkD* " of fZ -naphthylamine Released) •
mq. prNaph/IOOml.
Serum/hour
Figure 27 Effect of pH Changes In the ~nz-
ymatic Splitting of L-Cystlne-di- ^-naphthy-
lamide by a Late Pregnancy Serum.
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activity (expressed as 0,D. of Bmnaphthylamlne released)
was found in the pK range 7»U to 8.2. The loss of activity
was more abrupt at higher pH readings than at lower ones#
2 "Qystine" Aminopeptidase Activity in 8era of Hon-
Pregnant females
The enzyme levels were determined in the sera of 20
healthy female subjects. The enzyme activity varied
between 0.17 and 0.59 mg* j!>-naphthylamine/100 ml. seruny'
/ JL .
hour, with an average of 0.30 (- 0.1) mg. Differences
were not detected between enzyme levels in sera obtained
in the follicular and luteal phases of the menstrual cycle.
3 'Cystine" Arolnopeptldase Activity in Sera of Pregnane
Animals
The sera of each of two pregnant rats, mice, cows,
sheep and pigs were tested; all animals selected were in
the last third of their gestational period. The results
are shown in Table 16, and reveal only traces of activity.
The levels were similar to those of non-pregnant human
sera.
k Pfre.ct._pf_.I^ibltj^8_o^.Cysllne.^minopepMda8.c Activlty
of Human Pregnancy Sera
The effect of inhibitors on the enzymatic splitting
of the synthetic substrate L-Cystine-di-y#-naphthylamide
by late pregnancy sera is shown in Table 17# which reveals
a similar pattern to their effect on the enzymatic
splitting of oxytocin. Substantial inhibition was produced
by CuM, Ag*, Zn++, and the metal-chela ting agents 8-hydroJsy-
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TABUS 16







Females tm 20 Q • UiO 14- O • _i> O
Pregnant Females
t
36-40 w 40 4.80 (- 0.12)
Pregnant Sheep 21-22 w 2 0.76
Pregnant Sow 11-12 w 2 0.72
Pregnant Cow 31-32 w 2 0*53
Pregnant Hat 2+ w 2 0.48
Pregnant Mouse 2* w 2 0.32
.'he Distribution of Cystine Aminopeptidase Activity In








Ag+ 7L.0 S5" - 92




p.Ghlormerc. benz. 0.0 0-0
E.D.T.A. (10""2M) 91 *0 46 - 100
8-Hyd roxy-quino1* 42.0 £- OS 1 VJ(
Comparison of the Effect of Inhibitors on the • neymatic
Splitting of Ocytocin and L-Cystine-dL^^-naphthylamide
by Late Pregnancy Sera
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quinoline and 8.D.T.A, Pe4"* and sulphly&ryl inhibitors
had very little effect. Similar results were reported
by Tuppy and Wintersberger (1960).
5 Recovery and Platrlbutlon of "Cystine" Aminosenttdaae
Activity after Ammonium Sulphate Fractionation
Four late pregnancy sera were investigated, Th©
results are shown In Table 18. After half saturation
with ammonium sulphate, an average of 77*5 per cent of
the enzyme activity was recovered in the supernatant, and
6,0 per cent in the precipitate. The average total
recovery was 83.5 per cent. A similar observation reported
by Werle and Semra (1956) on "oxytocinaae" activity.
, . i i V
6 Recover;/ and Distribution of "Cystine" Aminopeptidase
Activity after Paper "lectrophoresis
The maximum enzyme activity in sera of pregnant
women was found on the cathode side of the OL-globulin
fraction, with a considerable overlap both into and
q(0 globulin bands (Fig. 28 and Table 19). The total
recovery in three consecutive experiments averaged 31.4
per cent of the original activity in the sera. Ho
enzymatic activity was recovered in the albumin, ^ or Y
globulin fractions.
The results indicated that the enzyme did not occupy
a sharply defined band on paper electrophoresis, but was
recovered in theo^ globulin and o< , globulin bands, and
in the zone in between. Werle and Oemm (1956) reported a
similar percentage recovery of oxytocinaae activity after
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TABLE 18
Enzymetic Activity Expressed as Q.D. of Naph. Heleased
$nf ractionated ""Supernatant' Precipitate Seco'very
Seran
Oil 234 0*244 0.024 0.268
0*200 0.157 0.004 0.161
0*260 0.154 0.012 0.166
&JLZ5_ - , .0*120 Q»Q14 o»134
0.869 0.675 0.054 0.729
10C$ 77*5% 6*0% 83*5%
Distribution of Pregnancy Serum Cystine Amlnopeptldase
Following 50f Ammonium Sulphate Precipitation. The
Values for the Activity in Supernatant and Precipitate
were corrected for the Dilution
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WMLJL2
Protein Fraction Cystine Aminopeptldaae Activity Average %
Sxp. 1 Rasp, 2 Exp. 3 Sim Recovery
Albumin Band 0.10 0*07 0.0? 0.24 1.9
Globulin band 0.14 0.30 0.50 0.94 7.6
CX1 -C<2 OXobulin
Interval 0.43 0.63 0.70 1.76 14.3
C/g Globulin Band 0.23 0.30 0.20 0.73 5.9
and IfGlobulin
Bands 0.10 o .04 0.07 0.21 1.6
All Fractions 1.00 1.34 1.54 3.88 31.4
Unf rac t iona ted
Serum 3.15 4.21 5.00 12.36 100
Fractionation of Late Pregnancy Sera by Paper Electrophoresis.





re 2(3 SIcctrophores is of a Late Pregnancy Serum on
iellulose Acetate Paper, Showing the Various Protein Bands,
the Point of aaxlmum Cystine Aminopsptidaae Activity (marked
with an arrow), and the Range of Enzyme Activity (marked
with the straight line AB)»
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continuous electrophoresis of pregnancy sera, with the
highest activity in theo^^ globulin fraction# They how¬
ever, reported lower, but substantial, activity in the
albumin band#
7 Sfiae&dLSfiSLof,,the„J^^atlc,splitting of.jgggfftine-di-,
-naphthvlamlde and S-Benasyl-Cysteine- /3-naphtIxvlamm
by Pregnancy Sera
Parallel estimations were carried out on the sera of
2k women in various stages of pregnancy# The results are
shown in Fig# 29, which indicates a good correlation
between the two methods# In individual sera, the 3-Rensyl-
Cysteine substrate was split approximately 10 times faster
than L-Cymtine-dl-p-naphthylamide•
To test the specificity of the two substrates for
cleavage by early pregnancy sera (as opposed to non-
pregnancy sera) and their possible use as a pregnancy test*
Table 20 shows the average reading for 10 non-pregnancy
sera (B) and 15 serum samples from patients in the first
10 weeks of gestation (a)# The ratio a/B is nearly the
same for both substrates#
Conclusions
1 The ensyraatic splitting of the synthetic compound
L-Cystine-di-^-naphthylamlde showed the same general
distribution in human sera and in the sera of pregnant
animals as oxytocinaae* The ensyne responsible in human
pregnancy sera occupied the same position after electro-
1 ecu re 29 Comparison between the Ineyrnatle
Oplltting of 'j-Cystine-dl* £ -naphthylomide
(Method I) and 3-Benayl Cysteinyl- ^f-naph-
thylamiae (Method II) by Sera of Woman in the
Various Stages of Pregnancy. All Sesults




Source of fio. of Enzymatic Activity
Serum Ofcserv, Method I Method II
Hon-Pregnant (B) 10 ^ 0.3ii 3*80
(0.22-0,62) (2.16-7.20)
Pregnant 10 w. (a) 15 0.58 6.^2
(0.32-0.8) (3.60-9.30)
Ratio a/B 1.70 1.69
Comparison of the Two Chemical Methods fa* Oxytocinase
Estimation in the Diagnosis of Early Pregnancy. Enzymatic
Activities are Expressed as rag. ^-naphthylamine/100 ml.
Serum/Hour Released from L-Cystine-dl- fi-naphthylamide
(Method i) and 0. Benz. Cysteine-/-staph. (Method ii).
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phoresis and ammonium sulphate precipitation as oxytocinaae
and also had similar properties when tested by various
inhibitors# Thus there was every reason to accept cystine
aminopeptidase activity as a valid estimate of oxytocins*®
in human pregnancy sera#
2 The newer synthetic substrate# 8-1Jensyl«-Cystelne-
i*\naphthylamide was split more readily by pregnancy sera
than L-C,ystine-di~ ^ -naphthylamide and allowed quicker
estimation of enzymatic activity in micro litre volumes
of sera. It was not, however# a better substrate for





CUBICAL STUDIES OK FRHQNA*SCY SERUM 0XYT0CINA3B
In this part of the work, oxytocinaae activity was
investigated by the chemical method in the sera of women
at the various stages of normal pregnancy, labour and the
puerperium. Estimations were also carried out in the
various pathological conditions of pregnancy and labour.
To study the site of formation of the enzyme, the
distribution of oxytoeinase activity was investigated in
the different products of gestation, as well as in vitro
cultures of trophoblast. The serum levels were also
tested in female volunteers receiving oral contraceptive
tablets, which produce changes in the endometrium, not
unlike the decidua of early pregnancy.
The possible physiological role of the enzyme in
regulating myorne?trial contractility was examined in patients
receiving intravenous infusions of oxytocin in advanced
pregnancy with the purpose of induction of labour.
Material and Methods
Blood samples were collected by venipuncture as
described on page i+6 •
Blood samples from volunteers on contraceptive
tablets (Ovulen: Mestranol 0.1 rag. and Sthynodlal Diacetate
1.0 rag.) were collected between the 15th and 20th day of
the cyclic course.
Amniotic fluid samples were obtained by puncture of
the hind membranes by a Drew Smyth catheter in patients
in early normal labour, or those undergoing induction in
late pregnancy.
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Placental extracts were prepared by homogenising
normal term placentae in saline (1:1) as described on
page 57 • The enzyme content of the placenta was calcu¬
lated as twice that of the supernatant.
Cultures of human trophoblast were prepared by Dr.
K. Hashed from the placentae of cases terminated by abdom¬
inal hysterotomy in mid-pregnancy, using the technique
described by Harnden (1960) for tissue culture. Oxytocln-
ase estimations were carried out on the supernatant
culture medium after signs of growth had been observed
microscopically. The culture medium was changed every U&
hours and serial assays were carried out for 3 weeks. A
sample of the same culture medium (culture medium 199 + 2Cj^
AB serum) used in harvesting the tissue was employed as a
control.
All enzymatic estimations were carried out on the
synthetic substrate L-Cystine-di-^-naphthylamidc as prev¬
iously described on page 97 • The results are expressed
in rag. |B- naphthylamine/100 ml. serum/hour.
Results
Cerum Oxytocinsse bevels in formal Pregnancy
One hundred and twenty random determinations were
carried out in normal pregnant females between four and
forty weeks of gestation. The results are expressed in
Table 21 and Pig. 30 9 and reveal a gradual rise of oxy-
tocinase activity from the non-pregnancy level (0.3 - 0.1 Oj)
to an average value of U*8 (- 1.2) mg. ^-naphthy1amine/
100 ml# serum/hour near to term.
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u* to 8 weeks 10 0.6 0.16-0.6
8* to 12 weeks 10 0.5 0.6 -0.9
12* to 16 weeks 10 0.7 0.5 -1.0
16* to 20 weeks 10 1#1 0.8 —1.5
20* to 26 weeks 10 1.2 0.9 -1.6
26* to 28 weeks 10 1.9 0.9 -3.0
to 00+ to 32 weeks 10 3.1 1.6 -5.1
32* to 36 weeks 10 3.5 2.2 -6.5
36* to 41 weeks hO 6.8 2.8 —8.2
Normal Pregnancy Serum Oxytocinase Levels# All Values
Expressed as mg. ^-Naphthylamine/100 ml# Seras^/Hour.
5-i
4 8 12 1620 24 28 32 3b 40
Pregnancy Week
Figure 30 Average Values for Serum Gxytocin-
ase at Various Stages of Vnegnancy, in Labour,
and during the Puerperlum# Random Estinations*
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Charges in Qxytocinase Levels in Labour and In the
Puerperlum
Fourteen normal pregnant subjects were followed by
serial assays one to three weeks before term, in early
labour and one and six weeks after delivery. The results
are expressed in Table 22, The levels obtained in early
labour showed only minor changes from the late pregnancy
readings, A slight drop was observed in four patients,
and did not exceed 15 per cent of the late pregnancy leve}.
The enzyme level dropped to approximately i|0 per
cent of the labour value within one week after delivery,
and returned to non-pregnancy level by six weeks post
parturn,
inz.vfrte bevels in Abnormal Pregnancy and. -Labour
1 Threatened Abortion
Serum oxytocinase levels were examined in 15 patients
admitted to the antenatal ward with a diagnosis of threat¬
ened abortion at 16 to 20 weeks of gestation. The enzyme
levels varied between 0,? and 1,6 unite, with an average
of 1,05 (£ 0.28) rag, $'%laphthylamine/100 ml, serunv/hour.
The level is not statistically different from the normal
reading for this period of gestation (1,10 - 0.30 units)
(n r 23, t s 0.1, pj> 0.25).
Of these patients, four subsequently aborted within
one week. Their serum oxytocinase levels (0.8, 1.3, 1.0










£4 B. 4.5 5.0 ♦0.5 2.5 0.26
s.w. 4.2 3.8 -0.4 1.8 0.22
E.G. 3.9 4.7 +0.8 1.5 0.30
V.I. 5.0 5.0 0.0 2.4 0.50
M. R* 5.4 4.9 -0.5 2.2 0.28
H. S. 4.0 4.6 +0.6 2.2 0.24
Gr.B. 4.3 5.0 +0.7 1.5 0.25
S.B. 5.0 5.0 0.0 2.6 0.29
V. R. 3.0 2.6 -0.4 1.1 0.24
s. a. 4.8 5.1 +0.3 2.5 0.27
G. S. 4.5 4.7 ♦0.2 1.6 0.29
J.J. 2.8 2.9 40.1 0.7 0.31
J.D. 4.3 5.5 41.2 2.1 0.43
M. D. 4.8 4.3 -0.3 1.2 0.29
Average 4.4 4*6 40.2 1.8 0.29
Serial Asnays of Cystine Aminopeptidaae Activity In Late
Pregnancy, Labour and in the Puerperlum. All Results are
:xpres.;ed in mg. naphthylamine/100 ml. Serum/Hour.
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2 Uultiple Pregnancy
Fourteen eases of twins and one case of triplets
were Investigated between 3k and 40 weeks of pregnancy.
The average reading was 6.9 units (- 1.6) which is sig¬
nificantly higher than the late normal pregnancy reading
of 4.8 % 1.2 (n m 55, t m 4.5, P < 0.001).
3 Pre-eclampsia
Serum oxytocinase was determined in twenty pre¬
eclamptic patients between the 36th and 40th week of
pregnancy. Only patients exhibiting albuminuria (more
than a trace) with hypertension and/ar oedema were selects
for this study.
Snzyme levels in this group of patients ranged from
1.6 to 5.1 rag. ft. naphthylamine/100 ml. serum/hour, with
an average of 3*2 - 0.9 mg. When compared with the average
normal reading for this stage of gestation (4.8 - 1.2) the
difference is statistically highly significant (n = 58,
t « 3.3, p < 0.001).
4 Vesicular Mole
The serum enzyme level in a case ox* vesicular mole
diagnosed at 23 weeks of pregnancy was 1.2 units, which
falls within the normal range for this stage of gestation
(0.9 - 1.6). Following abdominal hysterotomy, the molar
vesicles were expressed and the enzymatic activity of
their fluid content was determined. A level of 1.0 mg.
.naphthy1amine/100 ml. serum/hour was found, which is
nearly Identical with the maternal serum activity.
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5 Uterine Inertia
Sena oxytoeinase was estimated in ten patients with
primary uterine inertia diagnosed clinically on the basis
of weak infrequent uterine contractions and prolonged
first stage of labour (+ 24 hours). The enzyme levels
ranged from 4.1 to 7.2 mg* ^jnaphthylamine/100 ml. serum/
hour (average 5*1 - 0.9 rag.)# The levels are not signifi¬
cantly different when compared to a level of 4*6 {- 0.7
units) found in the normal first stage of labour (n = 22*
t « 1.8* p 0.05).
distribution of the Tingyme in the Products of Gestation
1 Umbilical Cord Blood
Ten samples were investigated. The serum oxytocin-
ase ranged from 0.20 to 0.63 rag. ft-naphthylomine/100 ml.
serum/hour, with an average of 0.4 rag* The difference
from the non-pregnant serum reading is not statistically
significant.
2 Amniotic Fluid
The enzyme levels were determined in four specimens,
nly traces of activity (0.08 to 0.13 rag. ^.naphthylarainq/
100 ml. serum/hour) were found.
3 Placenta
The enzyme content of eight full term placentae
varied between 13*4 and 23.5 rag. ^-naphthylamine/100 gm.
wet placental tissue/hour* with an average of 19*0 (- 3-9)
.Tterlne Blood Levels
Six samples were investigated. Their serum oxy toe Inane
content was compared to the levels in systemic (arm) vein
rag.
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blood taken simultaneously# The results are ahown In
Table 23# and reveal no significant differences# The
small variations obtained are well within the range of
error of the chemical procedure#
Qxvtoeinaac Levels in the Sera of Subjects Receiving an
Oral Contraceptive
Nine volunteers were examined# The detail© of their
clinical histories and the serum enzyme activities are
shown in Table 2h» The average figure (G#31 - 0#1 units)
is not significantly different from the normal non-pregnant
control value of 0#30 (- 0.1) mg#^.naphUiylamine/lOC ml#
serum/hour#
Shangog in Serum Qxytoclmae Activity during: oxytocin
Infusion
Changes in the level of the serum enzyme were tested
in pregnant women requiring oxytocin infusion for inductioji
of labour near to term# The membrane had been ruptured
for 16 to 26 hours In all cases at the time of oxytocin
infusion# Blood samples were obtained at the start of
the oxytocin drip. In cases of successful induction, a
second specimen was collected at the time of stoppage of
the drip, usually half an hour after delivery of the
placenta# When operative delivery was undertaken, the
second sample was obtained immediately before obstetrical
intervention# The rate of oxytocin infusion was frequently-
adjusted according to the uterine response (assessed
clinically) and varied between 1 - 16 mU of oxytocin/min.
The clinical details and the results are shown in
TADLS23
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TABLE 2k
Hame Age Pariry Last
Delivery




M.S. 3k h+z 18 M 23 D 1 M 0.36
B.M. 32 k+° 32 M 25 D 2k M 0.26
N. A. 38 k*° 30 M 21 D 2k M 0.31
E.P. 29 2+1 12 M 2k D 10 M 0.3U
R. Q. 33 2+° 22 M 2k D 18 M 0.17
A. R. 21 0+0 • 2k D 20 M 0.52
M.L. 28 2+1 Ik M 22 D 9 M 0.27
H.R. 25 30 M 23 D 20 M 0.32






Serum Oxytocinase Levels of Patients on Oral Contraceptive
Tablets (Ovulen). Results Expressed in rng. ^-Naph./100 ml,
Se ruin/Hour.
TABLE25
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Tables 25# 26 and 2?. The duration of labour recorded in
these tables was the interval between the onset of regular
painful uterine contractions to the end of the third
stage of labour (expulsion of the placenta). Subjects
who were in established labour before starting the oxy¬
tocin infusion were excluded from this study.
In the majority of patients (Table 25)# no significan
changes in serum oxytocinsae were noted. The slight
variations noted in this group were well within the range
of error of the chemical assay procedure.
A significant increase of serum oxytocinase activity,
more than 10; of the pre-infusion level, was noted in 12
cases of successful induction. All cases of failed Induct
ion (ending in Caesarean Section) did not show this rise.
Comparing the average values for the data shown in
Tables 25 and 26 as regards the dose of oxytocin infused,
duration of infusion, length of labour, and pre-infusion
level of oxytocinase, the only significant difference is
the duration of labour, which was shorter in patients
who showed the rise in oxytocinase levels (18.8$), as
compared to subjects who did not show this increase. The
statistical analysis of the data is shown in Table 28.
In Fig. 31> the extent of rise in oxytocinase level
is plotted against the dose received. Ko significant
correlation can be seen. It may also be noted that
subject M.G., who received the largest dose of oxytocin
in this series, (15 0), did not show a rise in oxytocinase
levels.
TABLE28
















































Dose of Oxytocin Infused.
r iKUi'e
_ 31 Relationship "between Rise in
Serum Oxytocinase and Dose of Oxytocin
Infused.
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Oxytoclnase Production in Cultures of iroohoblast
Three cultures of irophoblast were investigated. The
selection of tissue chosen from the placentae for incubation
was done by micro-dissection, and the nature of the grow¬
ing cells was confirmed by the microscopic appearance of
the cells in the earlier phases of growth.
Controls showed a trace of cystine aminopeptidase
«■
activity of 0,08 to 0,13 units (probably due to their
serum content). The three cultures of trophoblast were
followed for 3 weeks. The levels recorded in 11 esti¬
mations varied between 0,08 and 0,12 mg. naphthylamlne/ j
100 ml, serum/hour.
conclusions
1 Random chemical estimations of serum oxytocinase
activity show a progressive rise throughout pregnancy to
a level of 4,8 (1 1,2) units near to term, with no sig¬
nificant change with the onset of labour. The enzyme
levels decline slowly after delivery, Apx roximately 405
of the labour values are still present one week post
partunu
2 The enzyme levels are significantly high in
patients with multiple pregnancy, and significantly low
in pre-eclamptic subjects. The enzyme levels in patients
with threatened abortion, vesicular mole and uterine
inertia in labour show no significant deviation from the
normal,
3 Following oxytocin drip for the induction of
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labour, a substantial rise of serum oxytoeiriaae activity
was noted in 12 out of 39 patients. The rise was not
related to the outcome of the induction, nor to the dose
received, but was associated with short labour.
U The serum oxytocins®© activity in uterine vein
blood is similar to the systemic levels.
5 No substantial oxytocinase activity could be
found in the sera of volunteers on oral contraceptive




?H2 MECHANISM OF IHACTIVATION OP OXYTOCIN AND VASOPRESSIN
BY PREonAITCY 3ERA
The present study indicates that the enzymatic deg¬
radation of pure synthetic oxytocin by sera of pregnant
women involves cleavage of the peptide bond between the
amino-terminal half-cystine residue (position 1) and the
tyrosine residue (position 2). The resultant open chain
compound has different values in both Bu-A solvent
(0«8i|) and Me-P solvent (O.hh) as compared with the parent
hormone (Rf O.li-3 and 0*83 respectively)# This open chain
polypeptide is not available for direct comparison. Its
nature, however, could be assessed indirectly by oxidation
which resulted in two components, one of which could be
identified as L-cysteic acid.
Tuppy and Nesvadba (1957)* reported a similar obser¬
vation. They, however, gave no experimental details and
did not define the values of the enzymatic degradation
product of oxytocin or its two components obtained by
subsequent oxidation.
In the present work, it also appears that lysine
vasopressin is cleaved by pregnancy sera by an analogous
mechanism. As speculated by Tuppy (19&Q), this is not
surprising in view of the fact that the two hormones have
the same amino acid sequence in this part of the molecule,
the difference being only in positions 3 and 8. Experi¬
mentally, the open chain degradation enzymatic product of
lysine vasopressin has an R^, 0.22 in Bu-A and 0.U4 in Me-P,
in contrast with the parent hormone which has 0.09 and
0.79 in these two solvents respectively. Subsequent oxi-
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dation leads to formation of two components# of which one
was identified as L-cysteic acid# It must be pointed out
that in our second solvent (lie-P) oxytocin and lysine
vasopressin, as well as their enzymatic degradation and
oxidation products# have almost the same R.,, values# TJn-
fortunately# I have been unable to obtain human (arginine)
vasopressin in a suitable concentration for similar exp¬
eriments# but it would be surprising if the results on
this chemically similar hormone prove any different.
In view of this identical process of cleavage# it is
difficult to accept that oxytocin and vasopressin are
inactivated by two different enzyme systems in pregnancy
sera. This opinion was held by Werl© (I9^0)with the
following arguments# which are based on the results of
biological assay experiments of serum oxytocinase and
vasopressinsse activity#
(a) Non-pregnancy female sera and sera of men have
substantial "vasopressinES©" activity, but are
devoid of oxytocin-splitting enzymes# As
pointed out by Tuppy (1960) this may be due to
the existence of an unspeciflc aminopeptidase
in the sera which is capable of attacking the
vasopressin molecule in areas not represented
in oxytocin, e#g. arglnlne (or lysine)~glycin-
araide bond. This does not rule out the present
argument that the specific pregnancy enzyme is
capable of inactivating both molecules by an
identical mechanism#
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(b) Pregnancy serum oxytocinase and vasopressinase
are affected differently by various enzyme
Inhibitors. Yierle*s short report (i960)
contains no experimental details, but it is
possible that the results of assay of residual
oxytocin and vasopressin were affected by the
influence of inhibitors on the assay preparatio
On© of the inhibitors employed (p-Chlormercuric
benzoate) was found by Hooper (1959) to inter¬
fere with the assay of vasopressin on the blood
pressure of rats.
There are several observations in the literature to
confirm this mechanism of action of pregnancy serum oxy¬
tocinase, as first proposed by Tuppy and Hesvadba (1957)
and confirmed in the present study.
(1) Btoklaska and Wlnteraberger (1959) reported
that purified pregnancy serum oxytoeinane preparations
inactivated both oxytocin and vasopressin at similar rates
(2) Berankova et al (1961) incubated late pregnancy
sera with synthetic peptide compounds representing frag¬
ments of the oxytocin molecule and assessed their rate of
cleavage by ninhydrin titration of free amino groups and
by paper chromatography. The results indicate that
pregnancy sera hydrolyse the compound s-benzylcystelnyl-
tyroelne (amino acid sequence 1 and 2 of the oxytocin
molecule), but do not split 3-benzylcyeteinyl-prolyl-
leucyl-glycine amide (amino acid sequence 6 to 9 of the
oxytocin molecule). By extending the rango of substrates
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they characterised the pregnancy enzyme as a specific
aminopeptidase which is distinct from tissue oxytocinase,
leucine aminopeptidase, earboxypeptidase, chyrnotrypeln,
dipeptidase and tripeptidase. These results were sub¬
sequently confirmed by Clhar et al (19&1) on a purified
pregnancy serum oxytocinase preparation.
(3) Glendening et al (1963) localised oxytocinase
activity in two specific bands by vertical starch gel
electrophoresis. The enzyme elated- from both bands was
capable of inactivating both oxytocin and vasopressin.
(4) ciolubow et al (1963) reported that the potent
synthetic analogue 1-isesaralno-oxytocin in not inactivated
by pregnancy sera. This compound, has exactly the same
structure as oxytocin except for the absence of a free
amino group in position 1, which thus seems to be essential
for the splitting of the molecule by the specific preg¬
nancy 3erum enzyme which acts as an "amino'*-peptidase.
PURIFICATION. PHYSIC0-Grv:;jICA4 PROPERTI S3 AND SUBSTRATE
iPVCIFICITY OF PfUBilAflCY SEWIM OXYTOCINASS
Purification of the enzyme has been attempted by
> M
Tuppy and Wintersberger (1960). employing retroplacental
serum" as a starting material, they achieved an overall
purification of 2300 - 4500 fold as estimated by the
specific activity per unit weight of protein. Puriflcatio
involved ammonium sulphate and rivanol precipitation,
removal of contaminants with bentonite and repeated column
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chromatography on hydroxylapatite, The preparation
appeared aa a single hand in horizontal starch gel eleotr<>
phoresis.
In the present study, paper electrophoresis indicate*
that enzymatic activity is recovered both in the and o(
globulin fractions and the zone in between. Similarly,
Page et al (1961) reported that in vertical starch gel
electrophoreals of pregnancy sera, oxyfcoclnase could be
recovered in two distinct bands, Cihar et al (1961) also
reported that during fractionation of pregnancy sera by
ethanol (according to the methods of Cohn et al, 1950),
oxytocinaae activity was distributed between the albumin
and globulin fractions. The two forms of oxytocinase
had different physico-chemical properties, but the same
substrate specificity and Inhibition properties. They
suggested that the two forms may differ in their content
of lipids or sugars, but have the same catalytic nucleus,
fuppy et al (1963) confirmed that the enzyme is a
glycoprotein, Pol owing Incubation of a purified prepar-
ation with neuraminidase, neuramic acid was released. The
removal of the acidic sugar molecules altered the electro*
phoretic mobility of the enzyme which still retained its
oxytocinase activity, Tuppy and Winte rsbe rger (I9&h)
suggested that a similar change might occur during the
fractionation processes, and could account for the occurr-*
ence of two forms of oxytocinase reported by other workers
The present study indicates that the enzyme Is a
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simple aminopeptldase, Tuppy and Neavadba (1957) reported
similar findings, and suggested that pregnancy scrum oxy-
tocinase is a specific "cystine" aminopeptldase acting on
molecules, which like oxytocin and vasopressin, possess
araino-termlnal half-eystine residues. Subsequent studies
on purified preparations confirmed that synthetic substrates
of such configuration are typical substrates for the
enzyme. These include
L-Cystine-&1-^-naphthylamlde (Tuppy and Hesvadba,
1957)
S-Benzyl-cyateinyl-^ -naphthylemide (Tuppy, 19&0
L-Cystine-dityrosinaraide (Winteraberger et al# 19SO)
S«Denzyl-cyateinyl-tyrocine (Berankova et al, 1961)
In addition, the enzyme Is also capable of splitting
| a wide variety of amino acid-^-naphthylanilde compounds
which lack this specific configuration (Tuppy and 'Winters*
berger, 1960), L-leucine- ^-naphthylaraide is split even
more readily that the cystine derivative. The label
"Cystine" aralnopeptidase ie thus only useful to indicate
the type of substrate usually employed to estimate oxy-
tocinase, but in no way embraces its amino acid substrate
specificity.
The only other aminopeptidaae that has been purified
and extensively studied is "Leucine" aminopeptidaae of
pig kidney (Smith and 3packoan, 1951)* In spite of the
nomenclature, this enzyme also proved to have a very broad
substrate specificity including peptides which carry
various amino acids, other than leucine, at their amino end.
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However, the cyclical structures of oxytocin and vaso¬
pressin possessing N-terminal half-cystine residues are
resistant to its action. (Hill and Smith, 1957). Beran-
kova et al, (19&1) and Cihar et al (1961) compared the
substrate specificity of axytoeinase and leucine amino-
peptidase, and concluded that they are different enzyme
systems# The same workers also reported that pregnancy
serum oxytocinase is different and distinct from oxytocin-
splitting ensymes in tissue extracts.
The results of the present study on the effects of
inhibitors correlate well with the report by Yuppy and
intersberger (i960) on a purified oxytccinase preparation#
The outstanding feature is the profound inhibition by the
raetal-chelating agents 8-hydroxyquinoline and E#D*T.A#
It is unlikely, however, that oxytocinase activity is dep¬
endent on dissociable metal ions, as the activity is not
affected by dialysis. Furthermore, all metal ions tested
in the present study and by Tuppy and Wintersberger (1960)
either inhibited or did not affect the activity of oxy¬
tocinase. It is thus more probable that oxytocinase
belongs to the group of metallo-enxymes with strongly
bound metal ions.
Purification of pregnancy serum oxytocinaee has not
been achieved on a large commercial scale; the obvious
difficulty is the limited supply of serum from women in
late pregnancy.
11+0
VALIDITY OF THTi CHEMICAL IJIRTHODS ?0R THE ESTIMATION OF
OXYTOOINASB
The synthetic substrate L-Cystine-di-^-naphthylamide
(Fig* 21) introduced by Tuppy and Nesvadba (1957)» shows
a chemical similarity to the N-terminal amino acid
sequence of oxytocin where the enzyme acts. It carries
peptide bonds joining amino-free half-cystine residues
with |B-naphthylamine, which pregnancy serum oxytocinase
seems to specialise in hydrolysing. On theoretical
grounds, the enzymatic splitting of this substrate, which
can be assessed by biochemical methods, should give a
quantitative estimate of pregnancy serum oxytocinase
activity.
Experimental proof for this view can be summarised
as follows:
(a) In the present study it was found that the syn¬
thetic substrate is very slightly split by sera of non¬
pregnant women and of pregnant cow, pig, sheep, mice and
rat, where oxytocinase has been reported absent or nearly
so (Werle et al, 1950; Page, 1946). On the other hand,
both oxytocin and L-Cystine-di-$ -naphthylamide were
readily split by sera of women in late pregnancy.
(b) As shown in the present study, the enzymatic
splitting of L-Cystine-di-y#-naphthylamide was affected
in a similar, almost quantitative, pattern by the various
inhibitors of oxytocinase. Tuppy and Wintersberger (1960)
working with a purified oxytocinase preparation, reported
similar findings.
11*1
(c) Fractionation of pregnancy sera by amionium
sulphate and paper electrophoresis in the present work
showed that the recovery and distribution of the enrymatio
activity towards L-Cyatine-di-^-naphthylamine is similar
to the oxytocinase activity as reported by Werle and r;emm
(1956)* Identical distribution of the two activities was
also reported by Page et al (19&5)t 0R starch gel electro-4
phoresis, and by Hashimoto (1961) following column
chromatography#
(d) Melan&er (19&3) carried out parallel assays of
the enzymatic splitting of oxytocin and L-Cystine-di-^-
naphthylamide at the various stages of pregnancy# A
linear correlation was found between the two sets of data
in the last two trimesters of pregnancy (correlation
factor "r" 0#9k)« However, this direct relationship was
sometimes lost at low enzyme levels in non-pregnancy and
early pregnancy sera, where the values of cystine amino-
peptidase activity were higher than oxytocinase#
The second substrate introduced by Tuppy and Winters-*
berger in 19"4 (S-Benzyl-cysteine-p-naphthylamide) was
found in the present study to give parallel results, but
was more readily split by pregnancy oera# Tuppy and
fJintersberger (196k) reported that this new substrate was
split 1k*5 times faster than L-Cystine-di-/^-naphthylamide#
In our experience, this factor was only 10#0 on the average.
Berankova et al (1961) employed the synthetic peptides
S-BenzyX-Cyeteinyl Tyrosine for the biochemical estimation
of pregnancy serum oxytoclnase# The underlying principle
1U2
is the same, but the results could only be expressed semi-
quantitatively by identifying the reaction products on a
paper chromatogram*
LIMITATIONS OF flu;: CHEMICAL MKTHQL? PGR ESTIMATION OF
mx&ax&M
The use of L-Cyotlne-di-^-naphthylamiae and. other
allied synthetic substrates for estimation of oxytoclnase
is based on a study of the exact mechanism of cleavage of
oxytocin by the specific enzyme in human pregnancy sera,
which acts as a specific ,Jcystine" aminopeptitiase# There
is little doubt that oxytocin can also be inactivated by
some other proteolytic enzymes (Croxatto et al, 19^2;
Eisaet, 1962)9 which may not have a parallel effect on
these synthetic amlnopeptidase substrates# It is also
quite possible that L-Cystine-di-^ -naphthylamide may be
cleaved by other aminopeptidase which are different from
the specific pregnancy serum enzyme# This overlap of
aminopeptidase substrate specificity (discussed by Naehlas
et al, 1962) imposes a limitation on the use of the chemical
method for evaluating "oxytocinase" activity in body fluids
and tissue homogenates, other than pregnancy serum.
Negative results in such experiments (e#g# in the case of
amniotic fluid) indicate absence of the specific cystine
ansinopeptidase of pregnancy sera# Positive readings, on
the other hand, unless backed by other evidence that the
responsible enzyme is identical with the pregnancy 3erum
1U3
factor, cannot be Interpreted as oxytaeinase activity*
Results on "tissue oxytocinase" estimations by this bio¬
chemical method (Melander, 1965) are thus very unreliable,
In the present study, although figures for cystine amino-
peptidase activity in placental extracts were; quoted, we
were only justified in reporting them because they were
nearly identical with the results of the biological assay
of "Placental oxytoeinase"• By both methods, the enzyme
content in one gm. of placental tissue was approximately
k times that of one ml* of late pregnancy sera. There is
also some evidence from electrophoresis experiments (Page
et al, 1961) that the responsible enzyme in placental
extracts is identical with pregnancy serum oxytocinnse*
As pointed out by Tuppy (1961) the low value©
obtained by the chemical method in non-pregnancy sera
(0*3 mg* ^-naphthylamine/100 ml. oeruiivhour in the present
study) may be due to the non-specific splitting of L-
Cyatlne-di- /3-naphthylamide by an aminopeptidese present
in all sera, and different from oxytoclnase* The presence
of such enzyme(s) is documented by the work of Rehal et al
(1963) and Green et al (1959)9 who reported substantial
cleavage of the aminopeptidaae substrate Leucine-^ -naph-
thylamide following incubation with sera of men and non¬
pregnant females. Tuppy's views are also supported by
Melander (1965) who found that the chemical method commonly
gave relatively higher values than the biological method
for oxytocinaae in non-pregnancy and early pregnancy sera.
Although most workers agree that oxytocinaoe is absent in
1h4
non-pregnancy sera. Page (19k€) could detect some inact-
ivation of oxytocin after prolonged incubation with non-
pregnancy sera#
Another limitation for the chemical method Is
imposed by the method employed for the colour development
of ^-naphthylamine released by ensymatic activity.
Sulphonamides and Sulphonurea compounds give the same
colour reaction. The additional readings cannot be
compensated for by the use of a aero time sample as a
blank (Melander, 1965). The method is thus not suitable
for assay of oxytocinase activity in the sera of pregnant
women receiving those drugs.
Although the chemical method can be used to study
the properties of the enzyme (e.g. pfl activity range,
effect of various inhibitors), it does not provide any
data on the kinetics of the enzymatic inactivatlon of
oxytocin by pregnancy sera such as reaction velocity,
half-life time or Michaelis constant "Km". Under the
conditions employed for estimation of oxytocinase by the
biochemical methods, excess of the synthetic substrates
is employed to ensure a zero order reaction, and not a
firet order curve. Moreover, the velocity constants are
different with different substrates.
VV ! ¥
The Km value for oxytoclnaee was estimated by bio¬
logical methods by Mendez-Bauer et al (1961) who gave a
figure of 5 U/ml. (lO^^H/litro), and by Melander (1965)
who reported a value of 1 U/ml• (0.2 x 10~ !<4/litre) • The
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half-life value for oxytocin incubated with late pregnancy
serum (or plasma) was given as less than one minute by
Page (1946), 10 minutes by Bicker and Y hyley (1959) and
15 minutes by Melander (1965), Under our conditions of
incubation, 30 - §0$ of oxytocin was inactivated in 10
minutes by sera of women in advanced pregnancy.
UBITS F03 OXYTOCINS AUGAY BY THX CHT-'MICAL METHODS
Under the present conditions of incubation, the
kinetics of the enzymatic splitting of the synthetic
substrate L-Cystino-di-£-naphthy1amide follow a zero
order pattern. The amount of ^-naphthylamine released
per unit time could thus be employed to estimate the
enzyme activity. For convenience, the unit actually
employed In this study was calculated as mg. y^.naphthy-
lamine/100 ml. serum/hour. This is the original unit
introduced by Tuppy and Neevadba (1957).
Melander (1965) followed the recommendations of the
International Union of Biochemistry in expressing oxy-
tocinase activity by substrate hydrolysis rather than
measurement of the reaction products. In zero order
reactions one international unit of enzyme activity is
defined as the amount which will catalyse 1 mlcromole
of substrate per minute during the initial stages of
the reaction. The units employed in this present study
can be transformed into international units/ml. serum by
multiplying by a factor of 0.58 x 10**^. Xlimek and
1M>
Pietrzycka (19&1) and Fylling (1963) expressed their
results in other units which have little to recommend thou#
ADVANTAGE OF THE amaiCAL a HTHOP OF OXYTOCINASS
As compared to the biological method* the chemical
method for oxytoclnase estimation is less laborious and
has higher accuracy and precision# With a good prepar¬
ation two 4-point assays of oxytocin on isolated rat's
uterus can be managed in one working day. By contrast,
oxytocinase estimations by the colorimetric method can be
done on three different specimens of sera simultaneously.
Although colour developaent was usually performed on the
next day, up to nine estimations could be managed in one
working day. The fluorimetrlc method is even more simple
and time saving.
The accuracy of the various methods can be deduced
from the average standard error in recovery experiments.
In the present study, the average error of oxytocin assay
on isolated rat uterus in recovery experiments was 11.8$.
In dialysis experiments, the colorimetric estimation of
oxytocinaee had a much smaller standard error of 1.0^.
In duplicate estimations the difference between the two
colorimetric readings was usually leas than 2jhf and rarely
exceeded the 5$ limit at low enzyme concentrations, which
also indicates great precision of this method.
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EVALUATION OF TH ■■■] RESULTS OF OXVTOCIKASE -RSTIUATION IK
NORaIAL AND ABNORMAL PR T:GKAifCY
The results obtained by the apeetrophotometrie raethoc
in the present study conform well with those of Muller-
Kartburg et al (1959); Titus et al (1960) and Melander
(19&5)* Table 29 compares the average figures for normal
non-pregnancy and late pregnancy sera quoted in the
various studies. The rise of enzyme levels by the end of
pregnancy is thus in the order of 16 - 29 times above the
non-pregnancy levels. As noted by Tuppy (i960) and con¬
firmed by Melander (1965), the chemical methods probably
give an unduly high estimate for oxytocinase activity in
non-pregnancy seraj the true rise in oxytocinase activity
may thus be higher than this.
In the present study it has also been established that
the oxytocinase content is higher in sera obtained from
patients with multiple pregnancy, similar results were
reported by Melander (1965) (on 6 patients), and by Qlen-
dening et al (1961) (number unspecified). In view of the
prevailing idea that the enzyme arises from the placenta,
this finding can be explained on the basis of increased
placental mass in such cases. The low values recorded in
subjects of moderate and severe pre-eclampsia could sim¬
ilarly be interpreted as a manifestation of placental in¬
sufficiency. The same finding was reported by Ichaliotis
and Lambrinopoules (1964), and is parallel to the deficient
steroid hormone excretion in such patients (e.g. Roy et al,
148
TABLK 29
Author Oxytocinsse Oxytocinase ! xtent of
Level In Non- Level In Rise
Pregnant Advanced
Subjects Pregnancy
Present Study 0.30 4.8 16 times
Mul1er-Ha rtburg
et al, 1959
0.20 5.6 28 times
Titus et alt
1960
0.20 5.8 29 times
Melander, 1965 0.29 5.0 17 times
Serum (or Plasma) Oxytocinase Levels# All Figures are
Calculated as tag* $-naph./l0G ml* Serum/Hour
1U9
1963; Robertson and Maxwell, 1963). Page (19^6) and
Aragon (I9h8) employing biological methods for oxytocinase
estimation, however, reported that the enzyme levels in
tozaemic patients ?^ere not different from the normal# The
low oxytocinase levels in toxaemie subjects could be a&-
oxytocin
vanced as an explanation of the increased^ sensitivity of
the uterus (Poseiro and Caldeyro-Barcia, 1958) and the
exaggerated antidiuretic response (Dieckmann and Michel,
to vasopressin
1935)Aln these patients* Hiad (unpublished observations)
however, employing Smyth oxytocin sensitivity test (1958),
was unable to establish a significant difference in the
uterine response between normal and toxaemic subjects in
late pregnancy#
In cases of threatened abortion (1S4 to 20 weeks of
gestation) the enzyme levels were not significantly diff¬
erent from the levels in normal pregnancy at the same
stage of gestation, even in patients who subsequently
aborted within one week# Melander (1965) reported a similar
finding# The same author also followed up cases of intra¬
uterine death in the second half of pregnancy, and reported
that the serum oxytocinase levels were still within the
normal range 1-3 weeks after foetal death#
There are few reports In the literature about serurn
oxytocinase levels in cases of molar pregnancy# In addition
to the case reported here, Hashimoto (19&1) and Melander
(1965) reported on two cases each# The serum enzyme levels
in all cases fell within the normal range# It is thus
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doubtful whether biochemical oxytocinase estimations will
be helpful in diagnosing a following up case of molar
pregnancy* The levels in the fluid expressed from the
molar vesicles in the present study were found identical
to the serum levels* This could be taken as further proof
that the hydropic change in molar villi is due to the
absorbtion by the active trophoblast in absence of foetal
villous capillaries*
Glen&ening et al (1961) reported that serum oxytoe
levels (estimated biochemically) are not raised in cases of
chorion epithelioma*
sinase
CI!APOES IK 3aRUM OXYTOCICS ACTIVITY IB IIOR^Ah AND II1DUC ■£
LABOUR
In the present work, results of serial assays of oxy>
tocinase activity in 14 patients revealed no significant
difference between the late pregnancy levels and those
obtained in early labour* A alight drop was observed in
4 patients, but did not exceed 15$ in any of them* Itis
thus difficult to attribute any role to the enzyme as a
causative factor in initiating labour* The same conclusion
was arrived at by Titus et al (i960)*
The serum enzyme levels in cases of uterine inertia
were also similar to those in normal labour* It is thus
unlikely that abnormalities in uterine activity during
labour are caused by altered enzyme levels* Babuna and
Jfenen (1966) however, reported that the enzyme levels are
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higher than normal in cases of uterine inertia. This
conclusion was not based on proper statistical analysis
of their published data, which show that the enzyme level
was less than the normal average in one out of 12 cases.
A rise in plasma (or serum) oxytocinase activity
during Infusion of oxytocin in pregnant women was reported,
by Mendez-Bauer (1961) and Tuppy <1961)# In the present
work, such a rise was established in 12 out of 39 patients.
Neither the occurrence nor the extent of this rise was
related to the dose of oxytocin administered, nor to the
uterine response to oxytocin, as fudged by the success
or failure of induction. The only positive correlation
was the frequent occurrence of this rise in patients who
had short labours after a successful induction.
The rise in serum oxytocinase activity that was
occasionally associated with oxytocin infunion could be
explained in various ways.
(a) Oxytocin infusion induces enzyme formation. ThlU
is difficult to accept in view of the fact that
the rise is in no way related to the dose
administered.
(b) The oxytocin induced uterine contractions lead
release of the enzyme from some intrauterine
source, e.g. the placenta or decidua. The frequent
occurrence of this phenomenon in successful
inductions with short labour, and presumably
excessive uterine activity, lends support to this
view.
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The absence of correlation between the outcome of
induction of labour by oxytocin and changes in the serum
levels of oxytocinase confirms the report by Fyliing (196$).
In a later paper, the same author (19&0 reported that a
rise of oxytocinase was regularly noticed after a single
intramuscular injection of oxytocin (Pitocin 10 I.U.) in
early pregnancy (8 to 20 weeks). Ho similar experiments
were performed in the present work. The usual indication
for oxytocin infusion in early pregnancy is induction of
cases of missed abortion, which are relatively uncorroion.
It must be mentioned that, as previously stated, estimates
of oxytocinase activity in early pregnancy by the chemical
method are not completely reliable,
CLINICAL VALUE OF OXYTOCIKASS ^STIMATXQfl
Pregnancy serum oxytocinase estimations by biological
methods were employed by Page (19h7) and Seram (1955) for
the diagnosis of early pregnancy. In the present work,
the values obtained by the chemical methods in early
pregnancy showed a wide overlap with non-pregnancy levels.
Single estimations wore not reliable for the diagnosis of
pregnancy before 16 to 20 weeks of gestation, by which
tirae the diagnosis of pregnancy could usually be estab¬
lished by chemical methods. The available methods based
on the detection of chorionic gonadotrophin hormone in
urine by biological or immunological tests are thus far
superior to oxytocinaae estimation. It is possible.
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however, that the latter assay may be of some use in
excluding pregnancy in the follow up of patients suspected
of having recurrence of vesicular mole or chorion epith¬
elioma on the basis of high gonadotrophin excretion values*
The present study excludes the possibility of employ¬
ing oxytocinase estimations as a method for assessing
gestational age with any degree of precision# Individual
variations around the mean value for any period of gestation
are so wide (Table 21) as to make any such predictions of
gestational age completely unreliable# These results are
at variance with the work of Page (19U6) and Semrn (1955)
who claimed that biological oxytocinase estimations were
useful for this purpose#
The levels of oxytocinase in advanced pregnancy or
the beginning of labour do not seem to reflect the pattern
of uterine activity In labour and are similarly not useful
in predicting the outcome of induction#
A. potential use of serum oxytocinase estimation may
be in differentiating maternal from foetal blood in late
pregnancy# This is occasionally required in diagnosing
the origin of bleeding In cases of antepartum haemorrhage
of doubtful origin, and in cases of a "bloody" tap following
attempted abdominal amniocentesis# The available chemical
methods (based on identification of foetal haemoglobin) do
not always provide a decisive answer# The levels of oxy¬
tocinase in foetal blood (0#4 8f* ^.naphthylamine/100 ml#
serum/hour) should be easily and decisively differentiated
from maternal blood levels (lu8 units)
15U
SITS OF CHIOIK OV PR.^AMar.-.3SRUa[ OXYTOCIHAGS
There ie a certain amount of indirect evidence In this
work as well as In reports by other workers, to indicate
that the enzyme is formed by the placenta# This can be
summarised as follows:
1 The enzyme is absent (or nearly so) in the sera
obtained from men and non-pregnant females#
2 Serum oxytocinase occurs only in pregnant women
and higher primates who have a haemochorial type of placapt¬
ation# It is absent in lower animals where other forms of
placentation do not allow such a close contact between the
trophoblast and the maternal organism#
3 The distribution of the enzyme in the products of
gestation is also suggestive of a placental origin# The
enzyme is nearly absent in the amniotic fluid and in the
foetal circulation, in contrast with the high and rising
levels in maternal serum throughout pregnancy# Placental
extracts are a rich source of oxytocin-splitting enzymes#
k The rising levele of oxytoclnase in maternal aera
throughout pregnancy show an analogous pattern to the
curve of placental growth, and are not unlike the progress
curves of other enzymes (e#g« histsminase) and steroid
hormones reported to arise in the placenta# The high
serum levels In cases of multiple pregnancy are also sugg¬
estive of a correlation with placental size#
5 Werle (i960) employing biological methods for
oxytocinase assay, presented evidence that the oxytocin-
t5"5
splitting enzymes in a variety of mammalian tissues, are
different from the specific oxyiocinsse in human pregnancy
oera# Tissue oxytocinases proved to be less stable and
had. different pH optima and inhibitor spectra# Similar
observations were made by Rychlik (1964) employing bio¬
chemical methods#
6 Semra (19G3) incubated slices of placental tissue
with the synthetic substrate L-Cystine-di-^ -naphthylamid©
under favourable conditions for oxytocinase activity, and
localised the y&-naphthylamine release by a hiotochomical
technique# He reported that the enzyme is localised in the
syncitial layer of the trophoblast# The limitations of th
use of the chemical methods for "oxytocinase" estimation
in tissues have been discussed on page 142 •
7 Glendenlng et al (1961) reported that placental
extracts subjected to vertical starch gel electrophoresis
showed bands of cystine amInopeptidase activity similar to
those obtained with late pregnancy sera# Ho similar bands
could be obtained by electrophoresis of extracts of the
myometrium, ovary, decidua or Fallopian tubes, in spite of
their substantial cystine aminopeptidaae activity#
In the present study, attempts at direct proof of the
placental origin of the enzyme have not been successful.
1 The effect of inhibitors on pregnancy plasma oxy-
tocinase (measured biologically) is somewhat different from
the results on oxytocin-splitting ensynie(e) in placental
extracts# Under similar conditions of incubation, the
placental factor is not Inhibited by metal-chelating agents
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In contrast to the plasma enzyme.
2 The enzyme content of the uterine vein blood
(which is the main route for drainage of the chorlo-decidu(al
space) la not higher than the levels in systemic (arm veirj)
blood obtained simultaneously. Such a gradient has been
reported with ©estrogens (Hoy, 19&2), progesterone (Zander
and Von Munatermann, 1954) and histamines# (Swanberg, 1950) i
all of which are thought to arise in the placenta.
3 The slow decline in serum oxytocinase activity
after expulsion of the placenta at tern delivery is difficult
to reconcile with a placental origin, and is different
from the rapid clearance of ©estrone and oestradial pro¬
gesterone and chorionic gonadotrophin following delivery.
Melander (1965) reported the same finding, and proposed
that the slow decline of the serum enzyme levels after
delivery could be due to the continued production by
decidual remnants. In the present study, the serum ozy-
toclnase levels in subjects receiving an oral gestagen
(which produces changes in the endometrium not unlike the
decidua of pregnancy) were not higher than the levels in
the normal controls.
TIf PHYSIOLOGICAL ROhBi OS' Plt^ANCY ^ THRUM OXYTOCINASK
It has been suggested that pregnancy serum oxytoclnase
is a protective mechanism which helps to regulate the levels
of oxytocin in blood, and to protect the human pregnant
uterus against sudden outbursts of neurohypophysial activity
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(Semn* 19611 Pylling* 196*4.)* There is very little evidenc
to support this hypothesis. The high levels of the ensyrae
in late pregnancy certainly do not suppress the uterine
response to injected oxytocin. On the contrary* the
sensitivity of the human uterus to oxytocin rises throughout
pregnancy (Pose and Caldeyro-Barcia* 1958) despite the
rising levels of oxytocinase* Melander (1965) also found
no correlation between the serum enzyme levels and the
onset of premature labour* In the present study* the
uterine response to oxytocin infusion in late pregnancy
(as assessed by the doses of oxytocin required for induction
of labour, and by the outcome of such induction) was in no
way related to the serum enzyme levels*
Similarly* Masai ct al (1965) reported that in late
pregnancy the uterine effects of infusion of Desamino-
oxytocin (which is not inactivated by serum oxytocinase)
do not last longer than oxytocin*
Furthermore, even in human males and in lov/er animals
who lack the sernn oxytocinaae enzyme* there seem to be
very efficient mechanisms for eliminating oxytocin from the
circulation* As seen in Table 3 (page 32 )f the half-life
of oxytocin in the rat, rabbit* sheep and human males* Is
not substantially different from the values obtained in
late human pregnancy* and does not exceed a few minutes*
It must be recalled* however, that the half-life values of
pituitary peptides in the circulation do not reflect on the
duration of the uterine response to oxytocin or the renal
effects of vasopressin, which last much longer (sica~Blanc£
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and Sala# 1961; de Warden©r, 1957)#
These discrepancies may be due to*
1 Half-life experimental data were based on the
administration of large doses of oxytocin and
vasopressin# If we accept that the hormones are
largely eliminated in the body by enzymatic inact-
ivation, these figures would not necessarily apply
to th© low physiological levels at which enzymatic
cleavage proceeds more slowly#
2 The Initial rapid clearance of the hormones from
the circulation may represent redistribution in
the various fluid compartments in the body rather
than final inactivatlon# Pitzpatrick (19&1)
reported that during one circulation of the blood
in the human male and the female sheep, a consid¬
erable proportion of intravenously injected oxytocin
seemed to diffuse beyond the vascular compartment#
Similar observations were recorded in the rat
(Ginsburg and Smith, 1959)* Arcsksr ©t al (19&k)
also found that following intravenous injection of
tritium-labelled oxytocin in the rat, radioactivity
was widely distributed in the body, even in areas
of low vascularity, e.g. brain substance and
muscle•
5 The sustained uterine and renal effects of posterior
pituitaiy hormones may simply represent rates of
recover^' of the target organs to the resting state




In view of the finding that^pregnoncy serum inactivates
vasopressin as well as oxytocin, it might be speculated
that the enzyme system is more concerned with water and
electrolyte changes in pregnancy than with regulating
uterine contractility. It is possible that the high
circulating levels of wrater and electrolyte retaining
steroids (aldosterone as well as placental steroids)
necessitates adjustment of the ~~'-f.renal effects of
vasopressin* This view can be tested comparing the
renal effects of vasopressin (injected or produced in
the test subjects by dehydration) in pregnant women as
compared to a group of non-pregnant controls. In a
recent work, Torres et al (1966) reported differences in
the electrolyte excretion response to injected 6-arginine
vasopressin in pregnant women, as compared with non¬
pregnant subjects. Intravenous infusion of arginine
vasopressin in raid-pregnancy led to a marked increase in
urinary sodium excretion. In the last trimester this
effect could not be reproduced, possibly as a result
of the high levels of circulating "vaaopreaalnase".
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